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Arginine is commonly used as an additive to enhance refolding yield of proteins 
and to suppress aggregation of proteins. However, the mechanisms through which 
arginine does so remain largely unexplored. Most of the studies available to-date 
on arginine-induced stability of protein solutions have focused on the preferential 
interactions of arginine with the proteins, but such an approach, while highly 
useful, is not necessarily sufficient to shed light on the specific molecular 
interactions that arginine has with protein residues. The focus of this thesis is to 
initiate a mechanistic study of arginine’s role in stabilizing protein against 
aggregation. 
 Firstly, we have developed a coarse-grained molecular thermodynamic model 
to extract some guidelines on the effects of an additive on aggregation reaction 
equilibria. The results show that the entropic effects (i.e., the excluded-volume 
effect) and the enthalpic effects (preferential attraction or exclusion) could 
dramatically alter the effects, even qualitatively, depending on the changes in the 
co-volume and the accessible surface area of the aggregates relative to that of the 
reacting monomers, thereby highlighting the fact that overall preferential 
interactions are not clear enough indicators of the effects of additives on 
aggregation. 
 Next, we present experiments to show that arginine can enhance heat-induced 
aggregation of concentrated protein solutions, contrary to the conventional belief 
that arginine is a universal suppressor of aggregation. The results show that the 
enhancement in aggregation is caused only for BSA and β-lactoglobulin, but not 
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for lysozyme, indicating that arginine’s preferential interactions with certain 
residues over others could determine the effect of the additive on aggregation. We 
use this previously unrecognized behavior of arginine, in combination with 
density functional theory calculations, to identify the molecular-level interactions 
of arginine with various residues that determine arginine’s role as an enhancer or 
suppressor of aggregation of proteins.  
 Finally, we present experiments and molecular dynamics simulations on the 
interaction of aromatic residues of proteins with arginine. An aromatic-rich 
peptide, FFYTP (a segment of insulin), and lysozyme and insulin are used as 
model systems. The results show arginine’s preference for both acidic and 
aromatic residues, in that order. In the case of aromatic residues, we note that 
cation-π, hydrophobic, and van der Waals interactions promote the alignment of 
the planar guanidinium group of arginine with the plane of the aromatic ring of 
the residues. Such an alignment would cause the polar end of arginine to protrude 
into the solution and to aid in solvating the arginine-aromatic pair, thereby 
assisting solubilization of aromatic moieties and aiding suppression of 
aggregation in the case of proteins.  
 Taken together, the work presented here provides new insights into some 
of the molecular mechanisms behind the effect of arginine on protein aggregation. 
Further, the approach we describe herein can be extended to provide a method for 
selecting suitable additives to stabilize a protein based on an analysis of the amino 
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1.1 THERAPEUTIC PROTEINS AND AGGREGATION 
Rapid development in protein therapeutics not only signifies the success of 
biosciences but also provides life-saving treatment against a wide range of 
disorders. Monoclonal antibodies, erythropoietins, interferons, growth factors, 
insulin, interleukins, tissue plasminogen activator, blood clotting factors, and 
replacement enzymes are some of the existing therapeutic proteins that have 
flooded both the research community and the business market (Brekke and 
Sandlie 2003; Business-Insights 2007). The principal reason for the success of 
these therapeutic proteins is their high degree of specificity towards the target 
organ. Today, a variety of proteins can be produced with relative ease by using 
genetic engineering. Novel protein expression systems and advance purification 
and recovery processes allow biologically active engineered proteins to be 
manufactured and purified in high yield at a quite reasonable cost. 
 There are, however, many barriers to further the development of these protein-
based drugs. Most of these barriers are related to the stability of the protein 
molecule (both, the stability of the folded structure and stability against 
aggregation) (Wang 1999; Frokjaer and Otzen 2005; Wang 2005). The activity of 
a therapeutic protein depends on its unique 3-dimensional structure, which is an 
outcome of various intramolecular interactions within the protein. Each of these 
interactions is thermodynamically quite weak. In fact, because of these weak 
interactions proteins, like other polymer molecules, are not rigid in their structure. 
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The native form of a protein, which shows therapeutic activity, is an ensemble of 
various fully closed to partially open structures. Thus being marginally stable 
molecules, proteins can lose their activity. This deactivation can be through 
various pathways such as non-covalent aggregation, covalent aggregation, 
deamidation, oxidation, and denaturation. 
 The problem of protein instability manifests in various stages of protein 
production, purification, storage, and drug delivery. For example, in selecting an 
appropriate mode of delivery of protein therapy, oral, intravenous, or 
intramuscular routes of the protein’s administration are not always effective 
because the protein can be metabolized before it can enter the target tissue. 
Subcutaneous delivery is one possible way for the delivery of the therapeutic 
proteins, but the subcutaneous route requires high protein concentrations in the 
range of 10-100 g/l (Wang 1999, 2005). At such high concentrations, proteins 
tend to aggregate and lose their therapeutic activity (Shire et al. 2004). 
Aggregated proteins are of great concern as they can trigger immunogenic 
responses (Carpenter et al. 1999; Krebs et al. 2007). Proteins also tend to degrade 
when stored over a long period. Minor alterations in the environmental/solution 
conditions can cause proteins to undergo deamidation, deoxidation, partial 
unfolding, or aggregation, which leads to protein deactivation (Frokjaer and Otzen 
2005). Apart from the post-formulation stages of a therapeutic protein, 
aggregation can also occur during pre-formulation stages. For example, 
unfavorable circumstances such as high temperature, pressure, extreme pH, salts, 
etc., encountered during the purification steps can deactivate the protein (Tsumoto 
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et al. 2004; Vedadi et al. 2006; Arakawa et al. 2007b). In addition, during the 
refolding step of protein manufacturing, aggregation and misfolding compete with 
proper refolding, leading to low yield of active protein (Shiraki et al. 2002; 
Arakawa et al. 2007b). All of the above-mentioned circumstances amply illustrate 
that marginal stability of protein molecules severely hampers the development of 
therapeutic proteins. Even as low as 1% conformational impurities at the end of 
the labeled shelf life are often unacceptable for protein-based drugs (Frokjaer and 
Otzen 2005). 
 Amongst various degradation pathways that a protein can take, aggregation is 
most common and is also challenging. In particular, the aggregated proteins, 
depending on their toxicity, can trigger normal to severe immunogenic responses 
and thus have deleterious consequences. Moore and Leppart (1980) have 
demonstrated that patients injected with a 50% to 70% aggregated human growth 
hormone solution developed antibodies against the aggregated proteins. Further, 
the authors also show that solutions containing even less than 5% aggregated 
proteins can trigger an immune response in some patients. In another report by 
Suzanne Vink-Hermeling of Octoplus (Workshop on Protein Aggregation, 
Breckenridge, CO, September 2006) the author show that  up to 90 % of the 
patients developed antibodies when dosed with 1-year-old marketed protein drugs 
such as Avonex®, Rebif®, Betaseron®, etc. These data indicate that (i) proteins 
can aggregate under normal storage conditions and (ii) protein aggregates can 
trigger undesired immune responses. In certain cases protein aggregates can also 
be strongly toxic (Demeule et al. 2007). A few examples of aggregation of 
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proteins (therapeutic and non-therapeutic) occurring under normal environmental 
conditions are (i) rhDNase completely aggregates within 30 days at 40 oC (Chen 
et al. 1999), (ii) bovine insulin aggregates in 2 days when stirred at 100 rpm at 37 
oC (Sluzky et al. 1992), (iii) recombinant human growth hormone aggregates even 
within 1 min of vortexing (Katakam et al. 1995), and (iv) α-antitrypsin aggregates 
1.5 % per week at 4 oC (Vemuri et al. 1993).  
1.2 ADDITIVES FOR PROTEIN STABILIZATION 
A relatively simpler and efficient way to prevent protein aggregation, with a 
minimum loss in the therapeutic activity of the protein, is the use of suitable 
excipients in the formulations (Gokarn et al. 2006). Excipients such as amino 
acids (arginine, glycine, proline, lysine), sugars (glycerol, sucrose, xylitol), salts 
and buffers (NaCl, phosphates, citrates), surfactants (polysorbate 20), etc., are 
being commonly used in protein formulations (see Table 1.1). Depending on their 
concentration, effects on proteins, and functioning mechanism, excipients (or 
additives, in general) are known by different nomenclatures such as cosolute, 
cosolvent, crowders, osmolyte, etc. In this work, we generally refer to excipients 
as additives. Some examples of the use of additives, in reference to the above-
mentioned examples of protein aggregations are as follow: (i) 1% CaCl2 can 
completely inhibit aggregation of rhDNase (Chen et al. 1999), (ii) 10 mM of n-
dodecyl-β-D-maltoside can preserve the activity of bovine insulin for 40 days 
(Sluzky et al. 1992), (iii) 0.1% of tween-80 can inhibit aggregation of rhGrowth 
hormone (Katakam et al. 1995), and (iv) 0.9 M NaCl can bring down aggregation 
of α-antitrypsin to 1% per week (Vemuri et al. 1993). Apart from efficiently 
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suppressing protein aggregation, most of the additives act as bulking agents, are 
biocompatible, and are only needed at low concentrations. For the above reasons, 
additives find wide use in biopharmaceutical industries (Marshall et al. 2003; 
Gokarn et al. 2006). 
 







   
Buffers/Salts citrate, phosphates, 
sulfates, acetate, 
etc. 
Almost all drugs 

















Antioxidants EDTA Kineret®, Ontak® 
   




*Source: (Gokarn et al. 2006) 
  
 Apart from the commercial application, many of the above-mentioned 
additives are also used in research studies to stabilize protein solutions against 
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aggregation, and also for other related processes, such as to enhance refolding 
yield and to improve protein solubility. Unlike the real-time effects of an additive 
on protein aggregation, which is necessary for the commercial usage, researchers 
employ rapid-screening methods in order to promptly analyze the effects of 
additives. Such rapid-screening methods involve the use of elevated temperatures, 
multiple freeze-thaw cycles, extreme pH and ionic concentrations, etc. Although 
such accelerated studies are suitable for investigating the effect of an additive on 
protein stability at room temperature, they act only as an initial tool for screening 
of additives for formulations (Nosoh and Sekiguchi 1991; Carpenter and Manning 
2002).  
1.3 ON THE USE OF ARGININE 
Amongst the various additives noted above, arginine is one of the commonly used 
additives for protein stabilization. Arginine can efficiently suppress protein 
aggregation for almost all the proteins (Arakawa and Tsumoto 2003; Tsumoto et 
al. 2004; Baynes et al. 2005; Das et al. 2007; Nakakido et al. 2008; Ghosh et al. 
2009; Nakakido et al. 2009). Arginine helps in increasing the refolding yield of 
various antibody fragments (Buchner and Rudolph 1991), lysozyme (Shiraki et al. 
2002; Matsuoka et al. 2007), immunotoxins (Buchner et al. 1992), etc., and also 
helps in enhancing the solubility of aggregation-prone proteins (Golovanov et al. 
2004; Okanojo et al. 2005), as required for pharmaceutical applications. The 
effect of arginine on protein refolding is closely related to the ability of arginine 
to suppress aggregation of folding intermediates (Arakawa and Tsumoto 2003; 
Liu et al. 2007). Apart from these, arginine also finds a number of applications in 
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protein purification and in improving the yield of ion/affinity chromatography 
(Arakawa et al. 2007b). The use of arginine for protein stabilization is even more 
interesting as the side chain of arginine contains a guanidinium group, which is 
frequently used for protein unfolding in the form of guanidinium hydrochloride, 
although arginine itself does not have any strong influence on the structural 
stability of the proteins (Arakawa and Tsumoto 2003). A few examples on use of 
arginine to enhance protein stability are noted below:  
• Rudolph and coworkers were the first one to discover the aggregation-
inhibitory property of arginine. In their patent application (1990), the 
authors showed that arginine can enhance the refolding yield of tissue 
plasminogen activator.  
• Matsuoka et al. (2007), by studying the effect of arginine on heat-induced 
aggregation (at 98 oC) of lysozyme, demonstrated that 100 mM of arginine 
can reduce the aggregation rate of the protein to 50%. 
• Lyutova et al. (2007) report that even as low as 2 mM of arginine can 
inhibit heat-induced (48 oC) aggregation of alcohol dehydrogenase and 
DTT-induced fibrillation of insulin. 
• Das et al. (2007) observed that arginine efficiently suppresses aggregation 
of Alzheimer’s amyloid-beta (Aβ1-42). 
• Golovanov et al. (2004) studied solubilization of various sparingly soluble 
membrane proteins and showed that 50 mM of arginine can increase the 
solubility of the protein by 50%. More interestingly, the authors also 
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report that a 50 mM equimolar mixture of arginine and glutamic acid can 
enhance the solubility by 8 folds.  
• Tantipolphan et al. (2010) have studied the elution behavior of insulin 
formulation in presence of arginine. The authors report that an addition of 
5.7 mM of arginine to the eluent can decrease the higher oligomers 
content of insulin. 
1.4 MOTIVATION FOR THE PRESENT STUDY AND OBJECTIVES 
The driving force for this research is the question “How does arginine stabilize 
proteins against aggregation?”. There are several reports available in the literature 
on the effect of arginine on protein aggregation. Most of these reports discuss the 
effects in terms of the preferential interactions of arginine with proteins. Other 
reports attribute the role of arginine to change in the surface tension (Arakawa et 
al. 2007a) or to the specific interactions of the guanidinium group (Ghosh et al. 
2009) or the aliphatic segment (Das et al. 2007) of arginine’s side chain with the 
hydrophobic moieties on the proteins. (A detailed discussion on these proposed 
mechanisms is presented in the chapter on literature review.) However, none of 
the available reports, individually or taken together, present a clear mechanism 
behind arginine’s function. 
 As noted above, preferential interaction theory has been the common choice 
for explaining the effects of additives on protein stabilization. The theory was 
initially developed by Timasheff and coworkers (Gekko and Timasheff 1981a; 
Gekko and Timasheff 1981b; Arakawa and Timasheff 1984a; Arakawa and 
Timasheff 1985) to present a thermodynamics basis of the effects of additive on 
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folding-unfolding transitions of a protein. Without any loss of generality, the 
theory can be extended to explain the effects of additives on protein aggregation. 
In order to understand the overall effects of an additive on protein stabilization in 
terms of preferential interactions, it is necessary to compare the preferential 
interaction coefficient, ΓXP, a thermodynamic parameter that is a measure of 
additive-protein binding, for the native state with the one for unfolded/aggregated 
state of the protein. However, it has been generally proposed in the literature that 
ΓXP of an additive with the native state of protein alone is sufficient to predict the 
effects of the additives on protein stabilization (Tsumoto et al. 2005; Arakawa et 
al. 2007a; Schneider and Trout 2009). In particular, it has been suggested that 
preferential exclusion of additives leads to protein stabilization, whereas 
preferential binding has the opposite effect (Baier and McClements 2001; 
McClements 2001; Arakawa et al. 2007a; Schneider and Trout 2009). Although 
this holds for many additives such as sugars and salts (Gekko 1981; Courtenay et 
al. 2000; Mishra et al. 2005) that is not always the case. For example, 2-methyl-
2,4-pentanediol (MPD) is a strong destabilizer, although it is strongly 
preferentially excluded from native ribonuclease A (RNase A), (Arakawa et al. 
1990b). Likewise for arginine, a large amount of data is available in the literature 
(Kita et al. 1994; Schneider and Trout 2009; Shukla et al. 2009) on preferential 
interaction coefficient, and they indicate that, unlike in the case of other additives, 
the sign of ΓXP of arginine depends on the arginine concentration and on the 
protein. For example, arginine’s preferential interactions with Bovine Serum 
Albumin (BSA) and lysozyme are a case in point. At low concentrations (< 0.6 
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M) arginine is neutral (ΓXP = 0) with respect to BSA, but preferentially binds to 
lysozyme, whereas at high concentrations, it is preferentially excluded from both 
(Schneider and Trout 2009).  
 If one goes by the general thinking in the literature that only preferential 
exclusion leads to protein stabilization, the above data for BSA and lysozyme 
would imply that arginine will have different effects on BSA and lysozyme 
depending on the arginine concentration. That is, one would expect arginine to 
stabilize BSA only at high concentrations and promote aggregation of lysozyme 
at low concentrations. However, various experiments (such as those of Shiraki 
and coworkers (Hamada and Shiraki 2007; Matsuoka et al. 2007; Hamada et al. 
2009)) on aggregation of BSA and lysozyme indicate that arginine stabilizes the 
two proteins regardless of the arginine concentration, despite the difference in the 
(concentration-dependent) preferential interactions mentioned above. The above-
mentioned anomaly on the uncertainty on the use of ΓXP leads us to our first 
objective in this study: 
 Under what circumstances can preferential interactions predict protein 
stabilization? Apart from preferential interactions, what other factors can 
affect the thermodynamics of additive-induced protein stabilization? How 
do these factors contribute to aggregation or stabilization of proteins? 
To address the above questions, we use a coarse-grained molecular 
thermodynamic model based on liquid-state physics to extract some guidelines on 
the effects of an additive on aggregation. Although the coarse-grained model we 
use for the additive and the protein does not depict the finer details of the complex 
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interactions involved in protein aggregation, it is sufficient to shed light on the 
entropic and enthalpic effects of an additive on aggregation. 
 Even if relying on preferential interaction coefficient is sufficient to 
understand the effects of additives on protein aggregation, such an approach fails 
to shed light on the specific additive-protein interactions that contribute to protein 
stability. In view of this, in the present work, we focus further on specific 
molecular interactions of arginine with proteins to gain some insights to arginine-
induced proteins stabilization. Ideally, a molecular-level picture of interactions of 
an additive with protein will aid in developing strategies for efficient selection 
and design of additives. 
 Based on its molecular structure, arginine can be divided into three segments: 
the polar terminal (consisting of amine and carboxylic groups), the aliphatic 
segment (with the three methylene groups), and the guanidinium terminal. 
Amongst the three segments, the guanidinium group is thought to play an 
important role in protein stabilization, as has already been suggested by Arakawa 
and coworkers (Arakawa et al. 2007a) based on their observations on the 
solubility measurements of various amino acids in the presence of 1 M arginine 
and guanidine. In order to understand the role of the guanidinium group (as well 
as those of the other segments) we consider the following objective:  
 Compare and contrast the effects of guanidine and arginine on aggregation 
of some model proteins. Our intent here is to address questions such as: 
How does the guanidinium group of arginine interact with the various 
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residues on proteins? What are some of the possible implications of these 
interactions on protein stabilization? 
To do so, we study heat-induced aggregation of three commonly studied proteins, 
viz. BSA, lysozyme, and β-lactoglobulin, and examine the effects of arginine and 
guanidine aggregation. In addition, we use density-functional-theory calculations 
to identify the residues with which arginine interacts strongly.  
 As we shall show in Chapter 4, experimental and computational studies 
indicate that arginine interacts strongly with aromatic residues (in addition to 
others) on proteins. The aromatic residues often participate in protein aggregation 
because of their high hydrophobicity (Reches et al. 2002; Liu et al. 2004a; Li et 
al. 2010). For example, aggregation-prone zone of many of the proteins, such as 
for Alzheimer’s amyloid protein and for type-II diabetes-related protein, have a 
high aromatic content (Amijee et al. 2009). Therefore, to understand the effect of 
arginine/aromatic-residue interactions on protein stabilization we select as our 
next objective the following: 
 What is the preference of arginine to the various residues (in particular, to 
the aromatic residues) on a protein? What are some of the possible 
implications of such interactions on arginine-induced protein 
stabilization?   
As noted above, protein aggregation and arginine-induced suppression of 
aggregation are an outcome of myriads of intermolecular and intramolecular 
interactions. However, an understanding of some of these interactions sheds light 
on some aspects of the mechanism of arginine-induced protein stabilization, as we 
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highlight in this work. The results and discussions presented herein also could 
provide guidelines, based on the amino acid content of a protein, for the use of 
arginine. 
1.5 STRUCTURE OF THE THESIS 
The thesis is organized into six chapters. Chapter 2 contains a comprehensive 
literature review on protein aggregation and the mechanisms which have been 
suggested for arginine-induced protein stabilization. In chapter 3 we develop a 
coarse-grained, molecular thermodynamic model of aggregation to show effects 
of an additive on aggregation. Chapter 4 presents experiments on heat-induced 
aggregation of three proteins in the presence of arginine and guanidine and 
discusses the role of guanidinium group of arginine on arginine-induced protein 
stabilization. In chapter 5, we study the interactions of arginine with aromatic 
residues, and examine the role of arginine/aromatic-residues interactions on 
protein stabilization. Finally, some of the major conclusions and 
recommendations for future work are summarized in Chapter 6.  
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2. LITERATURE REVIEW 
2.1 OUTLINE OF THE CHAPTER 
As discussed in Chapter 1, protein aggregation is an extremely complicated 
process. In this chapter, we begin with a brief discussion on some mechanisms, 
and the factors affecting protein aggregation (sections 2.2 and 2.3), necessary to 
understand the effects of additives on protein aggregation. As also noted earlier, 
several attempts have been made in the literature to explain the effects of arginine 
on protein aggregation. In this chapter, we also discuss some examples of the use 
of arginine to stabilize proteins against aggregation and present a detailed analysis 
on the mechanisms suggested in the literature to explain arginine-induced protein 
stabilization (sections 2.4 and 2.5). 
2.2 PROTEIN AGGREGATION: CLASSIFICATION & PATHWAYS 
In the context of proteins, aggregation is a general term that encompasses various 
types of interactions. Protein molecules may aggregate by simple physical 
association without any change in the primary structure (physical aggregation), or 
with the formation of new bonds, such as disulphide linkages or oxidation 
(chemical aggregation). Physical aggregation, which is more common, can be 
further classified into native/non-native, soluble/insoluble, and 
reversible/irreversible aggregates. Based on the morphology, protein aggregates 
can also be classified as mirco-aggregates (soluble oligomers), ordered aggregates 
(fibrils, protofibril, and crystals), and disordered aggregates (amorphous). 
Depending on the conditions, a protein can form soluble or insoluble aggregates. 
Various factors affect protein aggregation, such as the protein structure and 
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environmental conditions. In the present section we present some of these factors 
and their role in protein aggregation. Before explaining these factors, we first 
make brief notes on the pathways and kinetics of protein aggregation. 
 The pathways of protein aggregation have been discussed extensively over the 
past three decades. Traditionally protein aggregation was believed to be driven by 
the unfolded state of a protein, but recent evidence conclusively shows that the 
intermediate states, consisting of significant secondary and tertiary structures, are 
the precursors to protein aggregation. Cleland & Wang (1992), for example, 
showed, based on a kinetic analysis of guanidine-induced refolding of bovine 
carbonic anhydrase B, that the molten-globule state of the protein, and not the 
fully unfolded state, leads to formation of initial dimers and trimers. Similarly, 
Istrail et al. (1999) also concluded, based on Monte Carlo (MC) computations on 
competing aggregation and the refolding process, that the aggregation process is 
primarily driven by the interaction of partially unfolded states. Partially unfolded 
states drive aggregation more than the unfolded states, because although the 
unfolded states have more hydrophobic groups exposed to the solvent 
environment, partially unfolded states or intermediate states can have contiguous 
hydrophobic patches (Wang 1999, 2005; Wang et al. 2010). Thus, the schematic 






Figure 2.1: Schematic representation of protein aggregation pathways indicating 
the involvement of a partially unfolded intermediate state of proteins 
in aggregation. 
 
 Next we discuss the kinetics of protein aggregation. Protein aggregation 
generally follows apparent first-order or second-order kinetics, indicating that the 
rate-limiting step is either the formation of the partially unfolded state (I) or 
protein-protein association (A), respectively (Wang 2005; Morris et al. 2009). 
However, depending on the type of protein and aggregation conditions, there are 
many exceptions, when aggregation can follow either higher or sub-zero orders of 
reaction (Sluzky et al. 1992; Hevehan and Clark 2000). After the formation of the 
aggregation nucleus (dimers or trimers), growth of protein aggregation takes place 
through monomer-cluster aggregation (equation 2.1), cluster-cluster aggregation 
(equation 2.2), or both (Patro and Przybycien 1994; Speed et al. 1997).  
  1m mI A A ++ →                                                 (2.1) 
                                                 m n m nA A A ++ →   (2.2) 
2.3 FACTORS AFFECTING PROTEIN AGGREGATION 
Aggregation of proteins depends on various factors. These factors can be broadly 
categorized into two sections: (i) internal factors arising from the intrinsic 





properties of a protein, such as the three-dimensional structure of protein, its 
disulphide linkages, aromatic content, and hydrophobicity, and (ii) external 
environmental factors, such as temperature, pH, and ionic concentrations. We 
emphasize here only some of these relevant factors. For further details one can 
refer to the specific review articles available on the topic (Wang and Dubin 1998; 
Wang 1999; Wang et al. 2010). 
 Primarily, the aggregation propensity of a protein depends on its amino acid 
sequence. Proteins with a high content of hydrophobic amino acids (aliphatic and 
aromatic amino acids) are more likely to aggregate (Calamai et al. 2003). For 
example, Fields et al. (1992) have demonstrated, using the mean-field lattice 
statistical mechanics theory that the aggregation behavior of a protein depends 
strongly on its hydrophobic composition. More recently, Chennamsetty et al. 
(2009) have experimentally demonstrated, using the SAP (spatial-aggregation-
propensity) parameter, that the hydrophobic residues create aggregation-prone 
moieties on protein, and that replacing hydrophobic residues in these aggregation-
prone moieties with hydrophilic residues leads to a decrease in protein 
aggregation. Hydrophobic amino acids consist of aliphatic amino acids and 
aromatics amino acids. Of the two, interactions between aromatic residues, 
because of their high hydrophobicity and planar structure, play an important role 
in aggregation (Reches et al. 2002; Reches and Gazit 2003; Liu et al. 2004a; Ma 
and Nussinov 2007a). For example, Islet Amyloid Polypeptide (IAPP) does not 
aggregate when the aromatic residues are mutated with non-aromatic ones 
(Reches et al. 2002). Phenylalanine zipper-mediated dimerization of adapter 
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protein with a PH and SH2 domain (APS) occurs due to the planar interactions 
between the aromatic residues (Dhe-Paganon et al. 2004). 
 Apart from the amino acid sequence, the secondary structure of proteins also 
plays a role in controlling protein aggregation. Generally, proteins with high β-
sheet content are more prone to aggregation than α-helices or random coils. A 
well-known example in this regard is the aggregation of amyloid peptide, where 
the protein undergoes a transformation from random/helix to β-sheets before 
aggregating (Soto et al. 1995; Soto and Castano 1996; Soto et al. 1996). Soto et 
al. (1996), with systematic mutations on beta amyloid peptide (Aβ1-40), have 
shown that the aggregation propensity of the protein is proportional to its β-sheet 
content. 
 Furthermore, external factors such as temperature, pH, ionic concentration, 
shaking, shearing, protein concentration, and metal ions affect protein aggregation 
(Lumry and Eyring 1954; Georgalis et al. 1997b, a; Tobitani and Ross-Murphy 
1997; Carpenter et al. 1999; Chi et al. 2003; Frieden 2007; Wang et al. 2010), 
primarily by altering the protein structure. Proteins are dynamic in their structure, 
with the native state of a protein being an ensemble of various native-like 
conformations. A slight change in environmental conditions can partially unfold 
the protein, making it more prone to aggregation. Moreover, pH and ionic 
strength can also affect protein aggregation by influencing the surface-charge 
density of the protein (Hegg 1982; Majhi et al. 2006). 
 Amongst the various external factors, temperature is the most critical. Heat-
induced aggregation is often used to study the effects of additives on protein 
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stability (Gekko and Koga 1983). Temperature can affect protein aggregation in 
various ways. Primarily, proteins unfold with an increase in temperature and thus 
expose the buried hydrophobic groups, thereby enhancing aggregation (Torrent et 
al. 2006). In addition, the frequency of molecular collisions also increases with 
temperature, and the hydrophobic interactions also become strong (Speed et al. 
1997). Increasing temperature also affects the secondary structure and favors the 
formation of β-sheets, which in turn promote aggregation. Because of the above-
mentioned reasons, almost all the proteins aggregate at high temperatures. 
Another important factor that affects aggregation is protein concentration (Fágáin 
1995; Wang 1999; Chi et al. 2003; Frokjaer and Otzen 2005; Cromwell et al. 
2006; Ricci et al. 2006; Chennamsetty et al. 2009). Due to an increased frequency 
of intermolecular interactions, concentrated protein solutions tend to aggregate 
rapidly. There are many such factors that affect protein aggregation, as noted 
above. The specific driving force of protein aggregation (hydrophobic 
interactions, charge interactions, etc.) varies with the type of protein and the 
environmental conditions. Although the molecular interactions between the 
residues that lead to protein aggregation is not always clear, several additives are 
known to enhance protein stability.  
 In the next section, we present a detailed discussion on the discovery of 
arginine as an additive and the various attempts that have been made in the 
literature to explain arginine-induced stabilization of proteins. It is important to 
note that the term “protein stabilization” is generally used in the literature to 
indicate stabilization of proteins against unfolding. However, our focus here is on 
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protein stabilization against aggregation. As far as possible, we will clarify the 
usage of the term “stabilization” in all further discussions, and unless specified, 
the term indicates protein stabilization against aggregation. 
2.4 ARGININE STABILIZES PROTEINS AGAINST AGGREGATION 
Additives have long been used in biotechnological industries for modulating 
protein stability. Some of the early applications include the use of salts and sugars 
in food industries to induce gelation in milk or egg proteins. Furthermore, urea, 
guanidine, and surfactants were found to be protein denaturants and solubilizers 
(Glazer and McKenzie 1963; Schellman 1978). However, the more recent 
developments on the use of additives for stabilizing proteins against aggregation 
were inspired by cell biology. Cells, under high osmotic stresses, accumulate low 
molecular weight components, called osmolytes, to prevent protein unfolding and 
aggregation (Yancey et al. 1982; Arakawa and Timasheff 1985; Qu et al. 1998; 
Saunders et al. 2000; Auton and Bolen 2005; Ignatova and Gierasch 2006; Street 
et al. 2006; Rosgen et al. 2007). Some examples of osmolytes are amino acids 
(alanine, glycine, proline), polyols (glycerol), TMAO, betaine, sarcosine, etc. 
Many of these low molecular weight osmolytes are used in in-vitro applications to 
stabilize proteins against denaturation based on their effect on protein stabilization 
in-vivo. In addition, they also prevent aggregation during refolding and storage. 
However, arginine is not an osmolyte. Yancey et al. (1982) report that arginine 
affects the activity of intracellular proteins and is required in high concentrations 
to suppress aggregation, and is therefore not used as an osmolyte by cells. 
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 The use of arginine to enhance the refolding yield of proteins was first 
discovered by Dr. Rudolph in the late 1980s. In an attempt to inhibit serine 
protease, Dr. Rudolph, while arbitrarily testing different inhibitors, added arginine 
in the solution during reactivation of the tissue-type plasminogen activator (tPA). 
Instead, in the presence of arginine, he observed an increase in the refolding yield 
of tPA. With this discovery, Dr. Rudolph patented an industrial process for 
development of tPA (Rudolph and Fischer 1990) by using arginine as an additive. 
Since then, arginine (or L-ArgHCl, as it is generally known as) has been used in a 
number of different applications to suppress misfolding and/or aggregation during 
protein refolding. Some examples include the use of arginine to enhance the 
refolding yield of Fab antibody fragments, immunotoxins, human interferon-γ, 
nerve-growth factor, and interleukin-21 (Buchner and Rudolph 1991; Kiefhaber et 
al. 1991; Tsumoto et al. 2004). The effect of arginine on the refolding of proteins 
has been studied extensively in the literature. During refolding, aggregation 
competes with proper folding of the protein, as the driving force is the same for 
both processes. It has been suggested in the literature that during refolding, 
arginine suppresses aggregation of the protein, but does not directly assist in 
proper refolding of the proteins. For example, based on their experiments on 
lysozyme and RNase A, Arakawa and Tsumoto (2003) have observed that 
although arginine prevents aggregation of both the proteins, it does not have any 
effect on the melting temperature of the proteins, indicating that arginine does not 
affect the folding/unfolding transitions of the proteins. Similarly, more recently, 
based on their refolding experiments on recombinant consensus interferon, bovine 
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carbonic anhydrase, recombinant human colony stimulating factor, and green 
fluorescence protein, Su and co-workers (Liu et al. 2007; Chen et al. 2008) 
showed that arginine (i) does enhance the refolding yield of all the proteins and 
(ii) can greatly suppress aggregation and precipitation of the proteins (Liu et al. 
2007). Thus, enhancement of the refolding yield in the presence of arginine is due 
to the suppression of protein aggregation.  
 Apart from preventing aggregation during refolding of proteins, arginine also 
enhances protein solubility. The work by Golovanov et al. (2004) is noteworthy 
here. Golovanov et al. used low concentrations (50 mM) of arginine and glutamic 
acid to enhance the solubility of sparingly soluble membrane proteins. They 
observed that even at low concentrations, arginine enhanced the saturation 
solubility of various proteins by approximately 50 %. More interestingly, the 
authors also observed that an equimolar mixture of arginine and glutamic acid 
enhanced the solubility 8 to 9-fold, although this is not directly related to the 
present context. Apart from its use for enhancing protein solubility, arginine has 
also been used to dissolve inclusion bodies of various proteins (Tsumoto et al. 
2003; Lee et al. 2006). Tsumoto et al. (2003), for example, showed that arginine 
can dissolve GFP aggregates. Moreover, unlike the traditionally-used denaturants 
such as guanidine or urea, arginine can preserve the native structure and activity 
of the protein while solubilizing the inclusion bodies. 
      Arginine is also used in elution chromatography for protein purification. 
Generally, a low-pH buffer is used to achieve proper elution. Under these acidic 
conditions, proteins lose their native structure and can aggregate. Arginine is 
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often used, even at low concentrations, in elution buffers to maintain protein 
stability. For example, recovery of the IgG4 antibody increased from 
approximately 10%, to 48 %  and 84 % in the presence of 0.5 M and 2 M of 
arginine in the elution buffer, respectively (Arakawa et al. 2004). Similarly, 10 
mg/ml (~ 50 mM) of arginine in the eluent decreased the reversible hexamers 
content of insulin in column chromatography (Tantipolphan et al. 2010). 
 Despite its frequent use in refolding, solubilization, and purification to 
suppress protein aggregation, how arginine does so is not clear. In the following 
section, we discuss several attempts in the literature directed at understanding the 
mechanisms behind arginine-induced protein stabilization.  
2.5  SUGGESTED MECHANISMS FOR ARGININE-INDUCED 
PROTEIN STABILIZATION 
Several attempts have been made to investigate the functioning mechanism(s) of 
additives. Most of these studies employ model proteins such as lysozyme and 
BSA to measure either the solution properties or conformational changes in the 
protein. Apart from their influence on solution properties, additives can also affect 
the exclusion volume and osmotic stresses, both of which are purely entropic 
phenomena. Furthermore, additives can also have specific interactions with 
protein groups that help to stabilize the proteins. We now discuss some of the 
reported mechanisms.  
 2.5.1 PREFERENTIAL INTERACTIONS 
 Amongst the various mechanisms that have been reported in the literature to 
explain the effects of additives on protein stabilization, the preferential interaction 
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mechanism has received maximum attention and has been repeatedly cited to 
explain the effects of additives on both protein folding/unfolding and protein 
aggregation. Preferential interaction quantifies the weak interactions between the 
additive and the protein and connects the effect of these weak interactions to 
solution thermodynamics. Based on thermodynamic arguments, one can show that 
when an additive is added to an aqueous protein solution, the chemical potential 
of the protein varies as follows (Baynes and Trout 2003): 
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(2.3) 
where trpµ∆  is the transfer free energy of the protein from the aqueous system to 
the additive system, m is molality, and the subscripts X and P identify additives 
and protein, respectively. The second partial derivative on the right hand side in 




∂ ∂ is defined as the preferential interaction 
coefficient ΓXP, which is a measure of the binding of the additive with the protein 
molecule. The coefficient ΓXP represents an excess number of the additive 
molecules relative to water in the vicinity of the protein, compared with the bulk. 
A positive value of ΓXP indicates preferential binding of the additive, i.e., a 
relatively stronger interaction of the additives compared with that of water. 
Conversely, a negative value of ΓXP indicates preferential exclusion of additive 
from the protein surface. The above equation of transfer free energy of a protein 
in the presence of an additive can thus be rewritten in terms of ΓXP as  
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(2.4) 
Assuming ideal solution conditions (i.e., at low additive concentrations) one can 
simplify (Baynes and Trout 2003) the above equation  as  
  trP XPRTµ∆ = − Γ  (2.5) 
The equation above, although based on ideal-solution conditions, is very useful in 
understanding preferential interaction mechanism. The equation indicates that 
preferential binding of additives (positive values of ΓXP) will decrease the free 
energy of the protein molecule and that preferential exclusion (negative values of 
ΓXP) will increase the free energy.  
 How does preferential interaction lead to protein stabilization? Several reports 
on additive-induced protein stabilization against unfolding discuss the 
mechanisms in terms of preferential interactions (Gekko and Timasheff 1981a; 
Gekko and Koga 1983; Gekko and Ito 1990; Timasheff 1995). Lee and Timasheff 
(Lee and Timasheff 1981) observed, based on their measurements of ΓXP of 
sucrose with different proteins, that ΓXP is proportional to the protein surface area. 
These authors proposed this as a general observation and suggested that unfolded 
or denatured states will have a larger preferential interaction coefficient compared 
with that of the folded-native state of a protein. In terms of thermodynamics, such 
a suggestion would imply that a preferentially excluded additive (for example 
sucrose) will increase the free energy of the unfolded state more than that of the 
native state (Figure 2.2) and will thus stabilize the protein against unfolding, 
whereas preferentially binding additives will favor protein unfolding. Through a 
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series of measurements with various additives and proteins, Timasheff and co-
workers (Gekko and Timasheff 1981a; Gekko and Timasheff 1981b; Lee and 
Timasheff 1981; Arakawa and Timasheff 1984a; Arakawa and Timasheff 1984b; 
Arakawa and Timasheff 1985) have successfully correlated ΓXP (in the case of the 
native state of the protein) with protein stabilization against unfolding. For 
example, well-known stabilizers such as glycerol, sucrose, low-molecular-weight 
PEG, and naturally occurring osmolytes like betaine were observed to be 
preferentially excluded from the proteins. Conversely, denaturants like guanidine 
and urea were observed to preferentially bind to the proteins. This has led to a 
general belief that preferential exclusion of additives will lead to protein 
stabilization and, conversely, preferential binding of additives will lead to 
denaturation. Although this is true for several additives, there are some 
exceptions, as noted in the chapter 1 of this thesis for the case of 2-Methyl-2,4-
pentadiol (MPD). MPD is a strong protein denaturant, although it is preferentially 
excluded from the native RNase A (Arakawa et al. 1990b) because of the strong 
binding of MPD to certain groups of RNase in its denatured state. This anomaly 
indicates that ΓXP is not proportional to protein surface area, but instead depends 





Figure 2.2: Preferential interactions affect the thermodynamic barrier for a 
protein to unfold. 
 
 How does preferential exclusion of additives lead to stabilization of proteins 
against aggregation? Several reports in the literature suggest that preferential 
exclusion of additives will also lead to suppression of protein aggregation. For 
example, Kendrick et al. (1998) attribute sucrose-induced stabilization of 
recombinant human interferon-gamma against aggregation to preferential 
exclusion of sucrose. Similarly, McClements and coworkers (Baier and 
McClements 2001; Baier and McClements 2003; Baier et al. 2004; Baier and 
McClements 2005) show, in their series of studies on heat-induced aggregation of 
BSA that glycerol, sorbitol, and sucrose are aggregation suppressors and suggest 
that the induced stabilization is because of the preferential exclusion of these 
additives from the native state of BSA. Although the aggregated state of proteins 
will, in general, have less surface area compared with the native state (which 
implies that the preferential exclusion of additives should favor aggregation), one 
must note that aggregation of proteins is preceded by the formation of partially-
unfolded intermediate states of surface area higher than the native protein. This 
implies that a preferentially excluded additive prevents protein aggregation by 
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suppressing the formation of the partially unfolded state. In fact, Kendrick et al. 
(1998) have experimentally demonstrated that sucrose, which as noted earlier is 
preferentially excluded, inhibits the aggregation of recombinant human 
interferon-gamma by suppressing the formation of the intermediate molten-
globule state of the protein. It is also important to note here that although a 
preferentially excluded additive would prevent the formation of intermediate 
states, such preferential exclusion would also favor aggregation of the 
intermediate states. By contrast, although preferentially binding additives would 
favor the formation of intermediate states, such a binding would also suppress 
aggregation. Thus, based on the explanation provided by the preferential 
interaction mechanism, protein aggregation can be understood as a balance of the 
effects of additives on the formation of intermediate states from the native protein 
and on aggregation of the intermediate state. Since either step of aggregation can 
be rate-limiting, it is difficult to theoretically derive any general guidelines on the 
effect of additives based on their preferential interactions.  
 There has been a great deal of emphasis in the literature on the preferential 
interaction coefficient of arginine. Several attempts have been made to measure 
the preferential interaction coefficient of arginine for native proteins. For 
example, elaborate densimetry measurements by Kita et al. (1994) showed that 
xpΓ  of arginine follows a non-linear trend with arginine concentration. At low 
concentrations (< 0.6 M), arginine preferentially binds to BSA, whereas at higher 
concentrations arginine is excluded. However, with lysozyme, arginine is 
excluded from the protein at all concentrations. More recently, Schneider and 
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Trout (2009) have repeated the densimetry experiments (and have independently 
confirmed the results with vapor pressure osmometry experiments). They 
observed qualitatively different values for ΓXP and reported that arginine is not 
preferentially bound to BSA at low concentrations (< 0.6 M), but is neutral (see 
Figure 2.3). At higher concentrations, Schneider and Trout reported preferential 
exclusion of arginine from BSA consistent with the measurements of Kita et al., 
albeit with different numerical values for ΓXP. Moreover, although Kita et al. 
reported preferential exclusion of arginine with lysozyme, Schneider and Trout 
observed preferential binding at low arginine concentrations (< 0.5 M). Schneider 
and Trout further suggested that because of the balance of volume of exclusion 
(which will be discussed later in section 2.5.4) and repulsion of arginine from the 
protein surface, the preferential interaction coefficient of arginine follows a non-
linear trend with arginine concentrations. In addition to these experimental 
measurements of preferential interaction coefficient, molecular dynamics 
simulations have also been reported, by Shukla et al. (2009), for lysozyme in the 
presence of 1 M arginine; the results show preferential exclusion of arginine.  
 In conclusion, the preferential exclusion mechanism may successfully explain 
the thermodynamics of protein aggregation in the presence of additives. The 
available data suggest that preferential exclusion of additives, in general, leads to 
protein stabilization. As arginine is preferentially excluded from the proteins at 






Figure 2.3:  Preferential interaction of arginine with BSA and lysozyme. The 
figure is taken from Schneider and Trout (Schneider and Trout 2009) 
and shows their measurements of preferential interaction coefficient 
(▲). The data are compared with the originally-reported preferential 
interaction coefficient values by Kita et al. (Kita et al. 1994) (■). 
 
 2.5.2  SURFACE TENSION 
 Salts and other additives modulate the surface tension of a solution, which, in 
turn, affects protein stability and solubility. An increase in the surface tension of 
water drives the protein molecule to attain a conformation with lowest possible 
surface area (Arakawa et al. 1990a, b; Arakawa et al. 2007a; Hirano et al. 2008; 
Nakakido et al. 2009). The effects of additives such as NaCl, alanine, (NH4)2SO4, 
and other salting-out agents on stabilizing proteins from unfolding under various 
stresses, decreasing the solubility of proteins, and (in the context of protein 
aggregation) promoting aggregation has been attributed to the change in the 
surface tension induced by these additives. On the other hand, it has been 
suggested that various organic solvents promote protein unfolding and suppress 
protein aggregation by decreasing the surface tension of water.  
 However, the contribution of the effect of change in surface tension by 
additives in modulating protein stability is limited, and therefore there are several 
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exceptions to this. For example, MgCl2 enhances protein solubility, although it 
increases the surface tension of water (Arakawa et al. 1990b). Similarly, arginine 
is also an exception to this rule. Although arginine enhances the surface tension of 
water, it suppresses aggregation. Timasheff and coworkers (Kita et al. 1994; 
Arakawa et al. 2007a) have reported data on the change in the surface tension of 
water in the presence of arginine. The data indicate that 1 M arginine increases 
the surface tension of water by approximately 2 dyne/cm and also that at high 
arginine concentrations, the rate of increase in the surface tension is low. As the 
surface tension does not increase significantly at high arginine concentrations, 
Tsumoto et al. (2005) suggest that arginine might cluster at such high 
concentrations. We will later emphasize in chapter 5 and Appendix C of this 
thesis that arginine does form clusters at high concentrations (Li et al. 2010). 
 2.5.3 SOLUBILITY OF AMINO ACIDS 
 The data on the solubility of amino acids in the presence of additives can 
provide additional insights into the effects of additives on protein stability. In 
particular, based on the solubility data, important information about the strength 
of various forces (hydrophobic and polar interactions) acting within a protein or 
between two proteins in the presence of additives can be gathered. A well-known 
example here is that of ethanol (Gekko 1981). The solubility data of different 
amino acids in the presence of ethanol show that the additive interacts favorably 
with the non-polar amino acids (cys, met, ala, gly, val, ile, etc.), but not with the 
polar amino acids (arg, lys, glu, asp, etc.). This implies that the hydrophobic 
forces between the non-polar residues of the protein are significantly weakened in 
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the presence of ethanol. However, the ionic and polar interactions will become 
stronger. Thus, ethanol will stabilize proteins when the aggregation is driven by 
hydrophobic interactions, but will not do so if the aggregation is driven by ionic 
or polar interactions. 
 The solubility data are generally reported in terms of transfer free energy and 
the two are related as 
 ( )ln /tr a wG RT X X∆ = −  (1.1) 
where trG∆ indicates the transfer free energy of amino acids from water to an 
additive solution, and Xa and Xw are the mole fractions of amino acids in the 
presence of the additive and in additive-free water, respectively. A negative 
transfer free energy of an amino acid would thus imply enhanced solubility of the 
amino acid in the presence of additives, whereas a positive transfer free energy 
would imply decreased solubility. 
 The solubility data for various amino acids in the presence of arginine have 
been reported by Arakawa et al. (Arakawa et al. 2007a). The authors observed 
that the transfer free energy of almost all the amino acids, except valine and 
isoleucine, is negative in the presence of 1 M arginine, indicating that arginine 
increases the solubility of the amino acids (See Figure 2.4). The data thus suggest 
that arginine can weaken both hydrophobic and polar interactions and prevent 
protein aggregation. From the solubility data, some information can also be 
gathered on the interactions between the additive and the side chains of the 
protein residues. The solubility data reported by Arakawa et al. (Arakawa et al. 
2007a) also show that arginine and guanidine interact with various amino acids in 
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a similar way. We intend to use this fact again in later chapters (see chapters 4 
and 5) to elucidate the role of the guanidinium group of arginine in protein 
stabilization. 
 
Figure 2.4:  Transfer free energies of various amino acids in the presence of 
arginine and other additives (Arakawa et al. 2007a). 
 
 2.5.4 EXCLUDED-VOLUME EFFECT AND OSMOTIC STRESS EFFECT 
 The excluded-volume effect is commonly used to explain the effect of 
molecular crowding within the cellular environment. Macromolecular crowding 
refers to a collectively high volume fraction (7−40%) of macromolecules such as 
various enzymes, DNA, etc., in a physiological environment (Hall and Minton 
2003). That is, the presence of a high volume fraction of macromolecules makes 
the environment “crowded”. There are various experimental and theoretical 
reports available in literature to show that crowding affects various intracellular 
reactions such as protein folding, protein-protein binding, protein-DNA complex 
formation, actin fibrillation, etc. (Zimmerman and Minton 1993; Cole and Ralston 
1994; Lindner and Ralston 1997; Berg et al. 1999; Berg et al. 2000; Ellis 2001; 
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Chebotareva et al. 2004; Tokuriki et al. 2004; Despa et al. 2006; Du et al. 2006; 
Minton 2006; Hu et al. 2007; Stagg et al. 2007; Engel et al. 2008; Zhou 2008; 
Zhou et al. 2008; Batra et al. 2009a; Batra et al. 2009b; Zhou 2009). A common 
practice for determining the effect of crowding is to study the phenomenon of 
interest in the presence of high concentrations of non-interacting macromolecular 
additives (in the context of macromolecular crowding, the additives are called 
crowders), such as high-molecular weight PEG, ficoll, dextran, etc. For example, 
Stagg et al. (2007) show that the presence of 400 mg/ml of ficoll-70 can enhance 
the melting temperature of flavodoxin by 20 oC. Lindner and Ralston (Lindner 
and Ralston 1997) demonstrate, based on their kinetic measurements of actin 
fibrillation, that polymerization of actin in the presence of dextran increases with 
an increase in dextran concentration. Similarly, a number of studies report that the 
presence of crowders (or additives) can strongly affect the rate of protein 
aggregation (Berg et al. 1999; Munishkina et al. 2004; Minton 2005b; Minton 
2005a; Engel et al. 2008).  
 The effect of crowders on protein aggregation and biochemical reactions has 
been ascribed to the excluded volume, which refers to the volume of the system 
that is not available for the reacting molecule because of the presence of the 
crowder. In principle, a reaction in the presence of crowders is driven towards the 
direction of minimizing the excluded volume or maximizing the free volume of 
the system so that the entropy of the system is maximized. However, the free 
volume in a crowded system depends not just on the total volume of the crowders 
but also on the total volume excluded by the reactants and products. For example, 
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as shown in figure 2.5, the blue region shows the free volume available to the test 
molecule. Clearly, both the available free volume and the volume of exclusion 
(pink region) depend on the dimensions of the test molecule and the size and 
concentrations of the crowders. Minton and coworkers (Hall and Minton 2003; 
Minton 2005b; Minton 2005a; Minton 2006; Zhou et al. 2008; Attri et al. 2010) 
have developed qualitative and semi-quantitative models to compute the effect of 
crowders on various reactions. These models suggest that the effect of crowders 
depends on the size and the volume fraction of crowders as well as also on the 
size of the reactant and the product molecule. We will present further details 
regarding these models, and other parameters involved in determining the effect 
of crowders, in chapter 3.  
  
Figure 2.5:  This figure, adapted from Minton (2006), illustrates the concept of 
excluded volume in the system. In (A) the available free volume for 
the test species is the entire region shaded blue. However, in (B) 
available free volume is small (blue color region) because of the 
size of the test species. The volume excluded by the test species is 




 Osmotic stress effect is another phenomenon which is related to the excluded-
volume effect. Based on Asakura-Oosawa interactions (Asakura and Oosawa 
1954), additives drive a protein molecule to attain closed conformation, either in 
the native form or in the aggregated state. The driving force for the interactions 
depends on the difference between the volume of exclusion by the additive and 
water.  
 Although, to the best of our knowledge, no report directly indicates the 
excluded volume as a mechanism behind arginine-induced protein stabilization, 
Schneider and Trout (2009) suggest that the excluded volume due to the presence 
of arginine is the reason for arginine to be preferentially excluded from the 
protein surface. In another work, Baynes et al. (Baynes and Trout 2004; Baynes et 
al. 2005) have hypothesized that arginine is a “neutral crowder” and the 
aggregation-inhibitory effect of arginine is due to a specific phenomenon 
originating from the osmotic stress, which the authors term “gap effect”. The 
hypothesis is based on a simple theoretical argument and can be described as 
follows: In order to form aggregates, proteins will initially come into close 
proximity of each other. For this to happen, the additive molecules present 
between the two proteins will have to be pushed out or “excluded from” the gap 
between two protein molecules (Figure 2.6). During this process, the additive 
molecules will be transferred from the region between the two proteins (where the 
additive concentration is generally low) to the bulk solution (where the additive 
concentration is relatively large). This transfer increases the concentration 
difference of the additives between the two regions further. Such a transfer of 
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additives against the concentration difference increases the energy required for the 
aggregation process. Hence, in the presence of additives, this additional energy 
barrier will decrease the protein aggregation rate.  
 
Figure 2.6:  Gap effect indicates that neutral additives give rise to an extra 
energy barrier required to create a gap (marked by the shaded 
region between two proteins) against the concentration difference 
of the additives. Baynes and Trout (2004) indicate that this extra 
energy barrier leads to protein stabilization.  
 
 However, the gap effect would imply that preferentially bound additives will 
increase the energy barrier when compared with preferentially excluded additive, 
because there are more additives to be displaced in the former case. Although this 
is against the general observation of preferentially excluded additive being a 
better stabilizing agent than preferentially binding additives, the gap-effect model 
provides a good description of how additives can prevent the formation of the 
transition state of aggregation without affecting the native state of the protein 
(Nakakido et al. 2009). Furthermore, Baynes et al. (2005) performed experiments 
to verify the presence of the gap effect with insulin and anti-insulin as a model 
system and arginine as the additive. In the presence of arginine there was no 
change in the melting temperature of insulin, but the reaction between insulin and 
anti-insulin decreased. It was explained by the authors that the mechanism of 
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stabilization by arginine was entirely due to the gap effect, as their theoretical 
predictions of the suppression of aggregation were close to the experimental 
observations. 
 2.5.5 INTERACTIONS OF ARGININE WITH PROTEINS 
 Apart from the above-mentioned mechanisms, which are nonspecific and can 
be applied to all protein/additive systems, attempts have also been made to 
identify the role of specific molecular interactions between an additive and a 
protein on stabilizing the protein against aggregation. For example, Rzepecki et 
al. (2004) showed that acetylated aminopyrazole prevents amyloid aggregation by 
forming strong hydrogen bonds with the backbone of the protein. The formation 
of hydrogen bonds between the protein molecule and the additive blocks the site 
for another protein molecule to associate or aggregate. More recently, using 
molecular dynamics simulations, Vagenande et al. (2009) demonstrated that 
glycerol strongly interacts with the different surface groups of lysozyme and 
forms hydrogen bonds. The authors described the importance of these hydrogen 
bonds on the role of the glycerol-induced stabilization of lysozyme. 
 A number of attempts have also been made to understand the molecular 
interactions of arginine with aggregation-prone groups of a protein; for example, 
Das et al. (2007) observed a binding of arginine with the Aβ1-42 protein fragment 
based on their chromatographic studies. These authors speculated that the 
aliphatic part of arginine’s side chain binds to the hydrophobic moieties on the 
protein to prevent aggregation. Ghosh et al. (2009) suggested, based on their 
circular dichroism and fluorescence measurements, that arginine binds typically 
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with the aromatic residues to subdue the population of aggregation-prone states of 
proteins. Although such molecular interactions present better insights into 
arginine-induced protein stabilization, little is known about the underlying details. 
One of our aims in this thesis is to identify the interactions of arginine with 
protein residues and to look further at the role of some of these interactions on 
arginine-induced protein stabilization. 
2.6 SUMMARY 
In summary, we have discussed some of the basics of protein aggregation, such as 
the pathways, kinetics, and factors affecting aggregation. We have cited a number 
of examples on the use of arginine for the stabilization of proteins against 
aggregation. The primary focus of this chapter is on various mechanisms 
proposed in the literature to explain additive-induced protein stabilization. In 
particular, explanations based on preferential interactions, surface tension, 
excluded-volume effect, gap effect and specific molecular interactions between an 
additive and a protein have been discussed in the context of arginine to establish 




3. EFFECTS OF ADDITIVES ON 
AGGREGATION – 
            A THERMODYNAMIC PERSPECTIVE 
3.1 INTRODUCTION  
Additives are commonly used in protein formulations to suppress protein 
aggregation. Additives influence experimental observables such as equilibrium 
constant and reaction rates. As discussed in chapter 2, a number of different 
hypotheses have been reported to explain the mechanism behind suppression of 
aggregation. Amongst these, preferential interactions and excluded-volume effect 
have received the most attention. While the preferential interaction mechanism is 
cited for explaining the effects of molecular-size additives, excluded-volume 
effect is used to explain the role of large macromolecular (polymers) additives. 
3.2 FOCUS OF THIS CHAPTER1
The present chapter deals with the thermodynamics of the effects of additives on 
aggregation. Although thermodynamics at its core does not provide mechanistic 
understanding (i.e., thermodynamics does not always reveal the type and nature of 
specific molecular interactions at play), it can still assist in providing sufficient 
details on how the various non-specific interactions between additives and protein 
modulate aggregation. The attractive or repulsive interactions between additives 
and a protein give rise to the enthalpic factors, which can be quantified in terms of 
preferential interactions (Anderson et al. 2002; Schurr et al. 2005; Shulgin and 
Ruckenstein 2006; Shukla et al. 2009), whereas the hard-sphere interactions 
 
                                                 
1 Bulk of this chapter is published as a research article (see Shah et al. 2011 a) 
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indicate the role of entropic factors, which are often discussed in the literature in 
terms of excluded-volume effect (Zimmerman and Minton 1993; Minton 2000; 
Minton 2001; Hall and Minton 2003; Minton 2005a; Minton 2005b, 2006; Zhou 
et al. 2008; Attri et al. 2010). In general, the papers currently available in the 
literature place emphasis on either the enthalpic factors or the entropic factors. 
We herein look for how a balance of these two factors affects aggregation and 
also seek to indentify the role of other parameters (strength of additive/protein 
interactions, additive size, etc). To do so, we choose a coarse-grained model for 
aggregation and study the effects of additives on the equilibrium conversion of 
singlets to aggregates. As noted in chapter 1, although the coarse-grained model 
for the additive and the protein does not depict the finer details of the complex 
interactions involved in protein aggregation, it can still shed light on the entropic 
and enthalpic effects of an additive on aggregation.  
 In the next section we describe our methodology to compute equilibrium 
conversion of model aggregation and follow up with results and discussion. 
Finally, the results are summarized and the chapter is concluded by discussing 
some of the implications of the study. 
3.3 MOLECULAR THERMODYNAMIC FORMULATION 
The extent of reaction α is a function of the activities of the reactants and 
products, and the activities can be calculated from statistical mechanics based on 
appropriate models. Here, we consider a general chemical reaction of n reactant 
monomers R polymerizing to product P, 





Figure 3.1: Schematic representation of the modeled aggregation reaction. 
 
in the presence of additives (or crowder, C) and denote the initial concentrations 
of the reactants and products by 0RC  and 0PC  respectively. For simplicity, we 
assume 0 0PC = . The concentration of the additives, CC , remains constant 
throughout the progress of the reaction. If the degree of reaction is α, the 
concentrations of R and P at equilibrium are 0 (1 )RC α−  and 0 /RC nα , respectively. 
The thermodynamic equilibrium constant K Θ  is then 
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 (3.2) 
where the γ ’s are the respective activity coefficients. The equilibrium constant 
K Θ  is constant at a given temperature. We define the stoichiometric equilibrium 



















Both K and α are related to the activity coefficients, which depend on the type, 
size and concentration of additive, as they affect the reactant and product 
concentrations. 
 Our objective is to determine the extent of reaction, α, using Equation 3.3 for 
a given type of reaction with a known initial concentration of the reactant and a 
given equilibrium constant for any arbitrary additive concentration. However, one 
needs to know the values of the activity coefficients of the reactants and products 
as functions of their concentrations. For this, we use a statistical/molecular 
thermodynamic formalism and treat the mixture of reactant, product, and additive 
as a multicomponent system of particles interacting via the Lennard-Jones (LJ) 
potential (and compare it with the Hard-sphere interactions; see reference (Hu et 
al. 2007) for more details). Although the LJ potential is a highly simplified 
representation for the interactions, we use it merely to allow a combination of 
Born repulsion and van der Waals attractions between the various species in the 
system. Moreover, this allows us to examine, in particular, the influence of 
attractive forces between the additives and the reactants and products and, more 
generally, the role of internal energy contributions on the effects of additives and 
thereby the interplay between entropic (i.e., excluded-volume) and enthalpic 
effects. 
 Thermodynamically the total residual Helmholtz energy reA  of a 
multicomponent mixture of single LJ particles and “chain-like” molecules 
containing LJ particles (“segments”) consists of two contributions, namely, (i) all 
the LJ interactions among the single particles, all the LJ interactions between the 
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single particles and the segments in a chain, and the LJ interactions among the 
segments within a chain, and (ii) the free energy of chain formation. (By a “chain-
like” molecule, we mean a string of particles, or “beads”, forming a molecule.) 
Thus, in the case of chain molecules, in addition to the contribution from the 
individual segments, a contribution owing to chain formation (ACF
  
) needs to be 
included, i.e.,   
re LJ CFA A A= +  (3.4) 
 The LJ contribution LJA  is determined using the modified-Benedict-Webb-
Rubin (MBWR) equation of state (Equation 3.5). The MBWR equation contains a 
number of parameters (ai, bi, and Gi
  
), which were evaluated by Johnson et al. 











= +∑ ∑  (3.5) 
where the coefficients ai and bi *ρ are functions of temperature,  is the total 
reduced density ( * 3ρ ρσ= ) and, σ  is the LJ atomic diameter of the segments. The 
mixture of the various components is approximated as a single fluid using the van 
der Waals one-fluid theory (vdW1). The cross interaction parameters (σij and εij
 The free energy owing to chain formation is evaluated using the Wertheim 
first-order perturbation theory for associating spherical molecules (see Blas and 
Vega (1997) and references therein) 
) 
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= −∑  (3.6) 
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where the summation is over all the components in the system, s is the total 
number of components, β is 1/kB iρT, and  and mi are the density and the chain 
length of ith
( ) ( )ii i ii iy gσ σ=
 component, respectively. At contact, the cavity correlation function 
for the LJ chains is given by the pair correlation function, (Blas 
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Finally, given the above expressions for the Helmholtz energy, the activity 
coefficients γi
  













=  ∂ 
 (3.8) 
 The extent of reaction can now be obtained by solving Equation 3.3 
iteratively. To begin the iteration we assume an initial, trial for α, which provides 
the initial *ρ .We then calculate the residual free energy (Are
iρ
) of the system using 
Equations 3.4 to 3.7 for this condition. The activity coefficients can be calculated 
from Equation 3.8 by again using the Equations 3.4 to 3.7 for a small increase in 
the . The new iterate for α is then obtained from Equation 3.2 using the 
calculated γi
3.4 DETAILS OF THE SPECIFIC REACTION MODEL 
’s. The iteration is repeated until convergence. 
We illustrate the effect of additives on an aggregation reaction, where monomers 
combine to form a product, which is modeled as a chain of beads in any 
orientation. The reactant monomer modeled with a bead of diameter σr = 50 Å 
(roughly corresponding to a protein with 200 residues; average dimension of an 
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intracellular protein). As the effect of additives depends on the relative 
dimensions of the product to that of the reactant (Chebotareva et al. 2004), for the 
product chain, we have used three cases with different diameter of the product 
monomer σp 
 To examine the effect of the additives, we first fix the value of the 
thermodynamic equilibrium constant in Equation 3.2, 
= 52 Å, 50 Å, and 48 Å. We begin with results for a dimerization 
reaction (with n of equation 3.1 = 2) and later present results with higher orders of 
aggregation. 
K Θ , at unity, without loss 
of generality. Further, for simplicity, the LJ well depth (ε∗ = ε/kBT, where kB
 As it is known that small additives (i.e., small relative to the size of the 
reactants and products) exert an influence stronger than that of larger-sized 
additives (see, for example, Chebotareva et al. (2004)), it is meaningful to focus 
on sizes of additives smaller than the reactant size. The diameters of the additive 
is denoted by σ
 is 
the Boltzmann constant) is assumed to be equal for all the participating molecules 
and is taken to be 0.5, at roughly the “room temperature” T, taken to be 300 K, 
unless otherwise mentioned. The use of LJ interaction implies that the additives 
are attracted to the reactants and products, and we refer to such additives as 
preferentially binding. 
C,S and we choose the magnitude of σC,S as 6.4 Å. In addition, to 
elucidate the role of additive size, we also consider another additive of slightly 
bigger size, σC,B 0RC = 12.4 Å. The initial concentration of the reactant  is assumed 
to be 0.003 mol/l, which is approximately the total intracellular protein 
concentration. For ease of reporting, the concentrations of the additives are 
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presented in the terms of their volume fraction, which varies linearly with 
molarity. For reference, 0.5 M of 6.4 Å and 12.4 Å additive corresponds to a 
volume fraction of 4.1 % and 30 %, respectively.    
3.5 RESULTS AND DISCUSSION 
 3.5.1 EFFECT OF ADDITIVES: INTERPLAY BETWEEN ENTROPY AND 
INTERNAL ENERGY 
 Our task here is to examine and highlight the thermodynamic origins behind 
the effects of the additives on the enhancement or inhibition of the reaction (or 
aggregation). Figure 3.2 shows the extent of dimerization in terms of α/α0 with 
varying volume fraction (φC) of the single additive, α0 is the extent of reaction in 
a additive-free environment, for the three cases (a) σr < σp and (b) σr > σp (b) σr 
= σp. Figure 3.2a (σr < σp) reveals that, for the conditions considered, the 
conversion could be enhanced up to as much as two orders of magnitude by the 
addition of additives, a fact that demonstrates the strong influence of the additives 
on the reaction. A similar effect is observed in the presence of pure CB as well, 
but the maximum in the conversion corresponds to only about a two-fold increase. 
It is also clear that the initial steep increase in conversion is arrested at larger 
additive volume fractions and that, in fact, the reaction could be suppressed and 
the conversion could be brought down to practically zero with higher volume 
fractions of the additive. Exactly opposite is observed in Figure 3.2b (with σp < 
σr), where the reaction is decreased by 2 orders of magnitude at low volume 











Figure 3.2: Comparison of effects of single additives with different sizes and 
different interactions (α0 = 6.6 × 10−3
 
). HS represents hard-sphere 
interactions. Small additives have stronger influence on 
biochemical reactions as compared to the large additives. The effect 
of additives depends on the relative dimensions of the product and 
the reactant.  
 We now explain the underlying thermodynamics based on our results for σp > 
σr  
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(Figure 3.2a). A similar explanation is valid for other results too. The increase 
and the subsequent decrease of α with the additive volume fraction as observed in 
Figure 3.2a indicates the influence of competing thermodynamic factors, namely, 
the competition between the internal energy change (which, in this case, favors 
the reaction) and the entropy change (which, here, suppresses the reaction). For 
purely hard-sphere interactions (see Figure 3.2a), for which entropy is the 
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deciding factor, the decrease in free volume arising from the presence of additives 
causes a decrease in the overall entropy of the system, thereby suppressing the 
reaction (when the product volume is larger than the volume of the reactants 
forming the product), i.e., a reaction will shift in a direction that minimizes the 
excluded volume, as already noted by Minton (see, for example, Minton (2001)). 
The level of suppression is lower for larger-sized additives at any given volume 
fraction of the additives since the number concentration is lower than one would 
have for smaller additives and, as a result, the entropic penalty is also lower. In 
Figure 3.2b, where the product has a lower excluded volume as compared with 
the reactant, the reaction is highly favored, for the reason explained above. Our 
examination of our system using the scaled particle theory shows that the results 
we observe here for hard-sphere interactions are also consistent with the 
predictions of the scaled particle theory (Hall and Minton 2003; Chebotareva et 
al. 2004). For example Hall and Minton (Hall and Minton 2003) also observed a 
decrease in equilibrium constant (Hall and Minton uses non-ideality factor 
n
R Pγ γΓ = as the measuring parameter; we use conversion as the parameter) with 
increasing product size and vice-versa. Recently, Zhou (2008) has also examined 
protein refolding for hard-sphere interactions using scaled particle theory and has 
shown that the folded form (assumed to be a hard sphere with a hydrodynamic 
radius of 20 Å) of the protein is favored over the unfolded form (taken to be a 
chain of 200 beads; equivalent hydrodynamic radius 50 Å), i.e., in essence, the 
reaction is favored in the direction of decreasing free volume.  In our case also, 
the reaction is favored in the direction of decreasing free volume for hard spheres. 
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 However, if there are internal energy contributions (from the configurational 
energy) (arising from the LJ interactions in the present case), the situation 
changes. One can show using simple geometric arguments that, for the case of σp 
> σr (a parallel explanation is valid for the other case), the accessible surface area 
(ASA) of the product is larger than those of the reactants forming the product (for 
a certain range of additive sizes, See Figure 3.3 for the dependence of difference 
of ASA and EVE on crowder size) and that as the additive concentration is 
increased the internal energy becomes more negative in the present case, thereby 
driving the reaction forward. The extent of this increase would be smaller for the 
larger additives since the number of near neighbors around the product would be 
smaller for the larger additives. The increase in conversion arising from internal 
energy considerations will be offset by the decrease due to entropic reasons, and 
the net change in conversion will attain a maximum as a function of the additive 
volume fraction, with this maximum being larger for the smaller additive. At 
concentrations well beyond where the maximum occurs, the reduction could be 
substantial, with the smaller additive being much more effective. For example, for 
the conditions used in the present paper, for a additive volume fraction of 0.25, a 
additive of size 6.4 Å reduces α/αo by almost four orders of magnitude, whereas a 
additive of roughly twice the size (12.4 Å) causes a decrease of about only a order 





Figure 3.3: Difference in the excluded volume (EVE) and the accessible surface 
area (ASA) between the reactant and the product of a dimerization 
reaction varies with the crowder size. 
 
 For the case with product volume smaller than that of the reactants (Figure 3.2 
b) the roles of entropy and enthalpy would be reversed, for the additives that are 
preferentially binding (i.e., attractive interactions, as the ones above) to the 
reactants and products. The entropy in this case would favor the reaction, whereas 
the enthalpy would inhibit the reaction. As the explanation provided above can 
project the effect of relative product to reactant dimension, henceforth we use 
only the case with σp > σr 
 We note that the effect of short-range attraction has been considered by Hall 
and Minton (2003) (for square-well interactions), who explain their results using 
an effective hard sphere size for the additive. But their study is limited to low 
strengths of interaction for which the reaction is still suppressed by the additives 
(i.e., there is no qualitative change in α); therefore, an effective hard-sphere 
approximation could be adequate. Results similar to Hall and Minton hold in the 
case of LJ interactions as well for ε
to demonstrate the effects of a mixture two additives. 
∗ (= ε/kBT) of about 0.2 or below, as shown in 
Figure 3.4. However, in the presence of sufficiently large attraction (ε∗
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is a qualitative change in the effects of additives as compared to the hard-sphere 
interactions, and this qualitative change cannot be explained with the help of 
effective hard-sphere approximations, as evident from Figure 3.4. 
 
Figure 3.4:  Effect of varying the strength of interaction on the equilibrium 
reaction in the presence of an additive (for products larger than 
reactants). The strength of interaction ε∗ (= ε/kBT) and the 
conversion in the absence of additives α0 are indicated in the figure. 
At low enough ε∗, the entropy continues to dominate and inhibit the 
reaction, and one could, in principle, describe the effects of the 
additives in terms excluded-volume effects using effective hard-
sphere diameters for the additives.  
 
 The effect would be clearly different when the additives are preferential 
excluded (repulsive interaction) from the reactants and products, as both entropy 
and the enthalpy work together to “stabilize” the reactant. Preferentially excluded 
additives would thus be the choice for stabilizing pharmaceuticals and therapeutic 
proteins from aggregation at high concentrations in drug formulations. Although 
this is valid only for the case when σp > σr
φt
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, proteins in general swell (gain more 
surface area by unfolding) during aggregation.  
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 Finally, we note that the effects discussed for above dimerization reaction are 
similar for a polymerization reaction, i.e., for chain-like products with more than 
two segments, as illustrated in Figure 3.5, where we have restricted the 
calculations, for simplicity, to a single reaction of n monomers forming a chain of 
n segments. We observe that the effect of additives increases strongly with the 
degree of polymerization, which is relevant as most of the biological reactions 
involve high orders of polymerization (Batra et al. 2009b; Qin and Zhou 2009; 
Zhou 2009). 
 
Figure 3.5: Effect of additives increases with the degree of polymerization. 
 
 3.5.2 A NOTE ON THE USE OF MIXTURE OF ADDITIVES 
 There are some interesting articles in the literature indicating that a mixture of 
two additives can be more efficient in enhancing/suppressing aggregation than if 
either of the additives is used individually (Zhou et al. 2004; Du et al. 2006; Zhou 
2008; Batra et al. 2009a). For example, Golovanov et al. (2004) have measured 
solubility of some membrane proteins in a mixture of arginine and glutamic acid. 
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The authors observed 8 to 9 folds enhancement in solubility of the proteins in 
arginine-glutamic acid mixtures as compared to 1-2 folds in the presence of either 
arginine or glutamic acid. Likewise, Du et al. (2006) demonstrated that a mixture 
of two macromolecular additives (PEG, ficoll, dextran, BSA, DNA, etc.) is more 
efficient in increasing lysozyme refolding yield and refolding rate as compared to 
single additives. Since our model can easily accommodate multiple additives, we 
herein also present the thermodynamic origin of the effects of a mixture of two 
additives on aggregation. With the similar parameters as used above and with two 
additives of 6.4 Å and 12.4 Å we observed (see figure 3.6) that a mixture of 
additives enhances the equilibrium conversion of our aggregation reaction, 
although it does so only at high volume fractions of the additives.   
 Given the above explanation of the effect of single additives, the influence of 
the presence of two additives illustrated in Figure 3.6 follows easily. At low total 
concentrations φt of the two additives, replacing the larger additives with smaller 
ones, i.e., increasing the fraction of the small additive, fC,S, leads to a monotonic 
increase in the extent of conversion as the enthalpic effect dominates for all the 
way up to fC,S = 1. At higher φt’s, however, entropic effect overtakes enthalpic 
gain as fC,S is increased beyond a point, thus leading to an optimal fC,S (for 
example see point A in Figure 3.6). For the parameters used in the present work 




Figure 3.6:  Effect of mixture of additives on the dimerization reaction. For 
sufficiently crowded situations (total additive volume fraction > 
18%) we observe an optimal conversion in the mixture of the two 
additives (maintaining total volume fraction constant).  
 
 We have also examined the influence of size difference between the two 
additives on α. In Figure 3.7, σC,S is kept constant at 6.4 Å, while σC,B is varied 
from 7.4 to 15.4 Å at constant φt = 0.2. We observe that the maximum in α 
increases with increasing size difference between the additives. This is a 
consequence of the fact that, for any fixed fC,S, replacing CB with CS requires a 
larger number of CS for larger CB. It, therefore, follows from the earlier 
discussion for monodisperse additives that the (favorable) enthalpic influence is 
larger in the case of larger CB
3.6 CONCLUDING REMARKS AND IMPLICATIONS 
.  
 The above discussions demonstrate the thermodynamic underpinnings of the 
effects of additives on aggregation equilibria and illustrate the role of enthalpic 
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interactions and the potential competition that could exist between enthalpic 
effects and the usually emphasized entropic effects. 
 
Figure 3.7:  Increasing the difference of size between the two additives will 
enhance the optimal conversion of the reaction. 
In general, the qualitative change in the shift, ∆α, in α resulting from the entropic 
and enthalpic effects may be conveniently summarized as  
Entropic Effect:   ∆α ∝S 
Enthalpic Effect:   ∆α
 ∆V  (3.9) 
H ∝
where  
 A × ∆ASA (3.10) 
∆V  =  the difference between the co-volumes of the product and the 
reactants forming the product (with the covolumes evaluated using 
additive molecule),  
∆ASA  =    the change in accessible surface area between the product and the 
reactants 
A   =    the affinity of the additive to the reactants and products (with 
preferential binding being positive and preferential exclusion 
negative).  
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 The subscripts S and H on ∆α stand for entropy and enthalpy, respectively. 
Equations (9) and (10) represent not only our results but also what has been 
reported in the literature, largely for excluded-volume (i.e., entropic) effects. The 
combined effects of enthalpy and entropy, however, cannot be represented by a 
single equation, as the relative magnitudes of ∆αS and ∆αH
 What can one learn about the way arginine functions as an additive from the 
above thermodynamic analysis? The results reported above reveal that based on 
the non-specific interactions between additives and protein, the effect of additives 
depends on the strength of additive-protein interactions and also on the 
differences of ASA and EVE between the aggregates and monomers. The 
differences in ASA and EVE, in turn, depend on the protein structure, sizes of 
protein units relative to the sizes of the units in aggregates, morphology of the 
aggregates, and size of the additive. The fact that the effect of additives could 
strongly depend on the above mentioned factors suggests that additives, in 
general, would work selectively: i.e., additive-induced stabilization would depend 
on the specific protein and the experimental conditions. Although this holds true 
in general, some of the additives like glycerol are generic in their effect on 
aggregation and are equally effective in suppressing aggregation for different 
proteins. For such additives, it has been observed that the nature of preferential 
interactions (exclusion for the case of glycerol (Arakawa and Timasheff 1984b; 
Kita et al. 1994; Timasheff 1995; Schneider and Trout 2009)), which quantify the 
additive-protein interactions (and give rise to the enthalpic factor), is strong and is 
 depend on the details 
of the interactions. 
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also independent of the choice of protein. And thus, assuming no significant role 
of entropic factors, one can explain the effects of these additives. 
 Arginine, on the other hand, is unique in its interactions. Arginine stabilizes 
proteins against aggregation under all circumstances for various proteins. 
However, unlike glycerol, the preferential interaction coefficient of arginine is 
strongly dependent on the choice of protein and its concentration. For example, 
arginine inhibits aggregation of both BSA and lysozyme at a concentration of 300 
mM (Shiraki et al. 2002). However, at 300 mM concentrations of arginine the 
preferential interaction coefficient of arginine in the case of lysozyme is positive 
(indicating preferential binding), whereas for BSA it is negative (preferential 
exclusion) (Schneider and Trout 2009). Considering these facts, it seems very 
unlikely that non-specific interactions (preferential interactions) between arginine 
and protein can provide a clear explanation of arginine-induced stabilization for 
different proteins. Moreover, as noted in chapter 1, although relying on 
preferential interaction coefficients may be sufficient to understand the 
thermodynamic of the effects of additives on aggregation, the coefficients do not 
incorporate the specific additive-protein interactions that contribute to protein 
stability. Thus, in view of this, in the following chapters, we do not focus on the 
non-specific interactions but look for specific molecular-level interactions 





4. EFFECTS OF ARGININE ON PROTEIN 
AGGREGATION AND THE ROLE OF THE 
GUANIDINIUM GROUP 
4.1 INTRODUCTION 
As noted in chapter 1, arginine is a well-known and popular choice as an additive 
for protein stabilization and is also used for preventing aggregation of proteins 
during refolding, elution, purification, and storage. In addition, arginine has also 
been studied extensively in combination with various model proteins such as 
bovine serum albumin and lysozyme to understand the functioning mechanism of 
the excipient (Shiraki et al. 2002; Tsumoto et al. 2005; Arakawa et al. 2007a; 
Hamada and Shiraki 2007; Ghosh et al. 2009), with most of the earlier attempts to 
understand functioning mechanism of arginine focusing on the preferential 
interactions. However, as discussed in section 2.5.1 and chapter 3, preferential 
interactions of arginine do not clearly elucidate the mechanism. Thus, to develop 
a clear understanding of the functioning mechanism of arginine we look 
henceforth into the specific molecular interactions of arginine with the protein 
residues . 
4.2 FOCUS OF THE CHAPTER2
Based on its molecular structure arginine can be divided into three segments, 
namely, the polar terminal segment (consisting of amine and carboxylic groups), 
the aliphatic segment (with the three methylene groups), and the guanidinium 
terminal. Amongst the three segments, the guanidinium terminal is generally 
 
                                                 
2 Bulk of this chapter is published as a research article (see Shah et al. 2011 b) 
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believed to play an important role in protein stabilization. As noted earlier in 
chapter 2, Arakawa and coworkers  indicate, based on observations on the 
solubility measurements of various amino acids in the presence of 1 M arginine 
and guanidine, that arginine’s interactions with amino acids is mediated through 
its guanidinium group. These authors further suggest that the aggregation-
inhibitory property of arginine could possibly occur because of the interactions 
guanidinium group of arginine with the aromatic residues. Therefore, in this 
chapter we specifically look for the interactions of the guanidinium group of 
arginine with various protein residues and also the possible role some of these 
interactions on protein stabilization. To do so, we compare the effects of arginine 
with guanidine on heat-induced aggregation of three commonly studied proteins 
(BSA, lysozyme, β-lactoglobulin). Further, we use these experimental results 
along with quantum chemical calculations to identify the type of molecular 
interactions that drive the association between arginine and various protein 
residues. 
 Although arginine (along with its derivatives like arginine-amide and 
arginine-esters (Hamada and Shiraki 2007)) and guanidine have been repeatedly 
claimed to be exceptional aggregation suppressor under various circumstances 
(Baynes et al. 2005; Das et al. 2007; Lyutova et al. 2007; Ghosh et al. 2009), our 
experiments, interestingly, reveal that both arginine and guanidine can in fact also 
enhance aggregation depending on the type of protein and protein concentration. 
For example, we observe that arginine, even at high concentrations (< 700 mM), 
can significantly increase the heat-induced aggregation of bovine serum albumin 
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(BSA) at 20 g/l. A similar enhancement in protein aggregation is also observed 
for β-lactoglobulin (BLG) but not for lysozyme (LYZ). As emphasized by 
Lyutova et al. (2007), insufficiency of data has obstructed the development of 
qualitative and quantitative model and understanding of the effects of arginine on 
protein aggregation. In view of this, our results presented here, showing an 
enhancement in protein aggregation, provide yet another facet of the behavior of 
arginine and in so doing allows us to suggest some mechanistic possibilities 
concerning arginine’s role in enhancement as well as suppression of aggregation. 
 In the following sections, we first present the experimental and computational 
methodologies. Next, the results for the effects of arginine and guanidine on heat-
induced aggregation of BSA, lysozyme, and β-lactoglobulin are reported. 
Subsequently, in the discussion section, we compute the interaction energy 
between the guanidinium group and different protein residues and investigate the 
role of some of the strong guanidinium/amino-acid interactions on protein 
aggregation. 
4.3 MATERIALS AND METHODOLOGY 
 4.3.1 MATERIALS 
 All the chemicals are procured from Sigma-Aldrich, Singapore. Bovine Serum 
Albumin (BSA; Product number A3059), Lysozyme (LYZ; Product number 
62970), and β-lactoglobulin (BLG; Product number: 61329) are used without any 
further purification. Arginine (product number 11009), guanidine (product 
number G3272) and 1X PBS buffer are used for all experiments.  
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 4.3.2 EXTENT OF AGGREGATION 
 Aggregation is generally induced by heating the proteins above their melting 
points to study the effects of additives on protein stability. Heat-induced 
aggregation enhances the rate of protein aggregation and also minimizes the 
complications arising from the structural changes occurring during the protein 
aggregation (Baier and McClements 2003; Baier et al. 2004). As well-known, 
such studies are useful to examine the stabilization effect of arginine as well as to 
understand some of the basic principles behind the use of other excipients. We 
have chosen to focus on heat-induced aggregation in the present study, following 
similar examinations reported in the literature, primarily to compare our 
observations with those published in the literature, and also to avoid the potential 
complications introduced by the folding/unfolding transitions and the population 
of various conformational states of the proteins at normal temperatures and to 
focus on the accessibility of arginine to all residues of the proteins.  
 We study heat-induced aggregation of BSA, lysozyme, and β-lactoglobulin 
with arginine or guanidine as the additive using temperature-controlled UV/Vis 
spectrophotometer (Cecil® Bioquest-2501 attached with a temperature 
controller). Change in turbidity of the protein solution is used as a measure of 
protein aggregation. Turbidity measurement is a conventional technique (Baier 
and McClements 2001; Baier and McClements 2003; Baier et al. 2004; 
Chanasattru et al. 2007; Chennamsetty et al. 2009) used to capture the effect of 
additives, including arginine (Lyutova et al. 2007), on protein aggregation. A 
series of concentrations of protein-additive (arginine/guanidine) solutions are 
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prepared by dilution of a stock containing protein and protein-additive(1 M). All 
the solutions are prepared in 1X PBS buffer and pH is adjusted to 7.0 (± 0.1) with 
HCl. While heating the samples, the cuvettes containing the samples are covered 
with mineral oil to retard evaporation. Samples containing a particular 
concentration of additive and protein were incubated at room temperature before 
inserting in the isothermal chamber (at 90 oC) inside the spectrophotometer. 
Isothermal changes in the absorbance are monitored at 600 nm wavelength as a 
function of time. The reproducibility of the results is checked with multiple 
independent runs. 
 4.3.3 COMPUTATIONAL METHODS 
 All the calculations presented here were carried out using the DMol3 
numerical density functional theory program (Delley 1990, 2000), implemented in 
Materials Studio 4.3 by Accelrys Inc. Double numerical polarized (DNP) basis set 
which includes all occupied atomic orbitals plus a second set of valence orbitals 
plus polarized d-valence orbitals were employed. Geometrical optimizations were 
carried out using the local density approximation (LDA) and Vosko-Wilk-Nusair 
(VWN) exchange correlation functional. Frequency calculations were performed 
to ensure that structures obtained were indeed minimum energy structures with 
zero imaginary frequencies. Optimized geometries were refined further by 
calculating single point energy using general gradient potential approximation 
(GGA) and Becke-Lee-Yang-Parr (BLYP) exchange correlation functional. 
Charges and spin populations were calculated by Hirshfeld and Mulliken 
population analysis. The effect of aqueous environment was accounted 
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approximately by computing single-point energies using COnductor-like 
Screening MOdel (COSMO) (Klamt and Schuurmann 1993; Klamt 1995) at the 
GGA-BLYP level.  
 Charge transfer and chemical bonds are, in most cases, well described within 
DFT with either the local density approximation (LDA) or the GGA to account 
for the exchange correlation energy of the electrons. However, DFT does not 
include London-dispersion forces (Ortmann et al. 2005; Chakarova-Kack et al. 
2006). While it has recently become possible to include such effects in a 
nonempirical way in DFT calculations for systems of practical interest 
(Chakarova-Kack et al. 2006), such calculations are still computationally 
expensive. However, dispersion interactions are compensated in DMol3 by other 
terms in the interaction energy (Andzelm et al. 2003; Natsume et al. 2006). As 
Andzeem et al. (2003) note, the so-called basis set superposition error (BSSE) 
approach is used to account for incomplete atomic basis sets in ab initio 
calculations of interaction energies. The BSSE contribution is expected to be 
small, as the DMol3 program uses numerical functions that are far more complete 
than the traditional Gaussian functions (Andzelm et al. 2003).  
 The configurational binding energy Eb between arginine and an amino acid 
was calculated by the following equation, 
  [ :: ] [ ] [ ]bE Arg AA Arg AA= − −   (4.1) 
where [Arg] stands for energy of the arginine molecule, [AA] is the energy of the 
amino acid, and [Arg::AA] represents the energy of the arginine-amino acid 
complex. The interaction energy includes the effect of zero-point vibrational 
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energy (ZPVE), which we obtained from normal mode analysis. Gibbs free 
energy at 298.15 K (room temperature) was calculated using the vibrational 
analysis from DMol3.  
4.4 RESULTS  
 4.4.1 ARGININE ENHANCES BSA AGGREGATION 
 We begin with some experimental results on BSA which demonstrate that 
arginine can enhance protein aggregation, contrary to what is commonly believed. 
For this, first, heat-induced aggregation of the protein in the presence of different 
arginine concentrations was examined through turbidity measurements. 
Isothermal changes in the turbidity of BSA solutions were monitored at 90 oC and 
at 600 nm wavelength. Initially the solution remained clear as it was heated to 90 
oC from the room temperature, and subsequently the unfolded proteins began to 
aggregate with turbidity eventually reaching a plateau, indicating complete 
aggregation. Figure 4.1, which presents the turbidity of a 0.3 mM BSA (20 g/l) 
solution as a function of time at different arginine concentrations ranging from 0 
to 800 mM, shows that, while the arginine-free BSA solution displays only mild 
aggregation (indicated by a slow monotonic increase in turbidity from 0 to about 
0.5 in 10 minutes), a significant enhancement in aggregation is seen in the 
presence of arginine at a concentration of 100 mM (as evident from a more-than-
four-fold increase in turbidity in about the same duration). Higher arginine 
concentrations (up to about 700 mM) lead to a monotonic decrease in 
aggregation, although the extent of aggregation still remains higher than in the 
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arginine-free case. In the presence of concentrations beyond 700 mM, however, 
arginine suppresses aggregation relative to the arginine-free case.  
 
Figure 4.1: Below a critical concentration (here ~700 mM), arginine enhances 
aggregation of the protein (here, BSA). The figure shows change in 
turbidity of protein solution in the presence of arginine 
(concentration marked by arrows) due to aggregation. Characteristic 
error bars are also shown. 
 
 These results also reveal the existence of two arginine concentrations, denoted 
here as Cthr and Cmin, that are noteworthy. Of these, Cmin represents the critical, 
minimum concentration beyond which arginine reverts to its well-known role as 
an aggregation suppressor relative to the arginine-free case. The second, Cthr (< 
Cmin), is a threshold concentration that delineates the onset of suppression of 
aggregation over the initial enhancement (if any). For the conditions shown, Cthr ≈ 
180 mM and Cmin ≈ 700 mM. These results demonstrate that arginine reverts to its 
well known role as a stabilizer only when it is used at concentrations beyond Cmin. 
We have ensured that the observed results are not a consequence of buffer 
variables (salt and/or pH) by testing at several other solutions conditions. The 
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results obtained remained qualitatively similar under all cases (although, 
understandably the magnitude of Cmin depends on the solution conditions). An 
example for the case of 20 mM phosphate buffer at pH 7.0 is shown in Figure 4.2. 
 
Figure 4.2:  Arginine enhances the aggregation of BSA (0.3 mM = 20 g/l) in 20 
mM phosphate buffer (pH 7.0) with varying arginine concentrations, 
indicating that the results observed are independent of buffer 
conditions. 
 
 4.4.2 PROTEIN CONCENTRATION DETERMINES ENHANCEMENT OR 
SUPPRESSION OF AGGREGATION 
 That the propensity for aggregation is strongly influenced by protein 
concentration (Wang 1999, 2005) is evident from the two sample cases in Figure 
4.3 (for 5 and 40 g/l of BSA with 0 to 500 mM and 0 to 1500 mM of arginine, 
respectively). The effect of arginine remains qualitatively the same as before, but 
Cthr and Cmin vary with protein concentration, as evident from figure 4.4, where 
the maximum aggregation rate (defined in the caption) is plotted as a function of 




Figure 4.3:  Effect of protein concentration on arginine-induced enhancement of 
aggregation. 
 
 Enhancement in aggregation below a minimum critical concentration (Cmin is 
about 450, 700 and 900 mM, respectively, for protein concentrations of 5, 20, and 
40 mg/ml) is noticeably evident, and the enhancement is significant below Cthr, 
which also increases with protein concentration.  
 
Figure 4.4:  Aggregation rate (defined as being proportional to the maximum rate 
of change of turbidity for a given set of protein concentration and 
arginine concentration) of BSA depends on protein concentration. 
The figure shows that Cthr, corresponding to the maxima in the 




 The data available in the literature, e.g., Ghosh et al. (2009) and Tsumoto et 
al. (2004) on heat-induced aggregation of BSA, do appear to support the well-
known belief that arginine is a good aggregation suppressor, even at as low 
arginine concentration (~ 100 mM), as we have used. However, the protein 
concentrations examined in these and other studies have been typically much 
lower than the arginine concentrations (100 mM arginine in comparison with 1 g/l 
of protein). Similarly, in various refolding experiments, where arginine is reported 
to suppress protein aggregation (Shiraki et al. 2002; Arakawa and Tsumoto 2003; 
Xie et al. 2004; Hamada and Shiraki 2007; Liu et al. 2007; Matsuoka et al. 2007), 
a relatively high arginine-to-protein concentration ratio is used (typically 100-500 
mM of arginine and less than 0.1 g/l of protein). Our experiments, on the other 
hand, are at relatively high protein concentrations (100 mM arginine to 20 g/l 
BSA), and show that arginine-induced enhancement of aggregation occurs only at 
a relatively high protein-to-arginine concentration ratio, as evident from the 
dependence of Cmin on the protein concentration. Beyond Cmin, when we overdose 
BSA solution with arginine, it acts as an aggregation suppressor. This explains 
why arginine-induced enhancement of protein aggregation was not observed 
earlier, as most of the studies use arginine at concentrations beyond the 
corresponding Cmin. Other studies on the thermal aggregation of concentrated 
BSA solutions in the presence of low concentrations of other commonly used 
additives such as glycerol, sorbitol, and sucrose [see McClements and coworkers 
(Baier and McClements 2001; Baier and McClements 2003; Baier et al. 2004; 
Baier and McClements 2005)] do not appear to show any anomalous effects of the 
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additives relative to the effect seen at low protein concentrations, indicating the 
enhancement in protein aggregation observed in the present work to be a unique 
feature of arginine. 
 There are a few other studies that show that arginine stabilizes proteins against 
aggregation even at very low concentrations. For example, Lyutova et al. (2007), 
using similar turbidity measurements, show that even as low as 2 mM of arginine 
can prevent heat-induced aggregation alcohol dehydrogenase. However, (i) the 
protein concentration used in their experiments was comparatively low (0.2 
mg/ml) and (ii) Cmin, apart from the protein concentration, also depends on the 
protein used, as we show next. 
 4.4.3 ARGININE ENHANCES AGGREGATION OF BSA AND BLG, BUT NOT 
OF LYZ 
 Arginine-induced enhancement/stabilization of protein aggregation depends 
on the type of protein, as seen from our results for BLG and LYZ at different 
arginine concentrations. We have chosen lysozyme as model because it has been 
studied very often to investigate the effect arginine on protein aggregation 
(Shiraki et al. 2002; Arnaudov and de Vries 2005; Okanojo et al. 2005; Hamada 
and Shiraki 2007; Nakakido et al. 2008), although at low protein concentrations 
(< 1 g/l). In addition, we choose BLG as another model protein as it differs 
significantly from LYZ in its pI and amino acid content. Results for heat-induced 
aggregation of 0.3 mM LYZ (4.4 g/l) and 0.3 mM BLG (5.3 g/l), at various 




Figure 4.5:  Aggregation of LYZ, unlike BSA or BLG, is not enhanced by 
arginine. 
 
 Figure 4.5a reveals that arginine does not enhance the aggregation of LYZ, in 
the concentration range used. However, arginine does enhance the aggregation of 
BLG, with Cthr = 300 mM and Cmin > 1000 mM (Figure 4.5b and Figure 4.6), 
indicating that arginine enhances aggregation of only certain proteins.  
 
Figure 4.6:  BLG (β-lactoglobulin), which has a similar percentage of acidic 
amino acids as in BSA, shows characteristic trends with both 
arginine and guanidine as observed for BSA, supporting our 




 4.4.4 GUANIDINE ALSO ENHANCES AGGREGATION OF BSA AND BLG, 
BUT HAS NO EFFECT ON LYZ 
 An interesting contrast is provided by an examination of the effect of 
guanidine, in the place of arginine, on the aggregation of the above proteins. 
Figure 4.7 shows the extent of aggregation of BSA and LYZ in the presence of 
arginine and guanidine. Our results show that guanidine enhances the aggregation 
rate of BSA much more than arginine at same additive concentration (Figure 4.8), 
but, unlike arginine, guanidine does not stabilize the protein as the guanidine 
concentration is increased. Similarly, guanidine does not stabilize LYZ, although 
arginine does.  
 
Figure 4.7:  Guanidine does not arrest aggregation at large concentrations, in 
contrast to arginine. 
 
However, in the case of BLG a trend qualitatively similar to that of BSA is seen 
(Figure 4.6). The results in Figure 4.7, suggests that the guanidinium group of 
arginine, in some way, participates directly in the enhancement of protein 
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aggregation. However, other fragments of arginine, i.e. the aliphatic part and the 
terminal (amine and carboxylic) cap, are necessary in arginine’s role as proteins 
stabilizer, as we shall discuss later. 
 
Figure 4.8: Guanidine enhances the aggregation of BSA more than arginine does 
for the same additive concentration. In the case of arginine, the 
methylene groups mitigate the effect of the guanidinium group, 
which promotes aggregation. 
 
4.5 DISCUSSION 
As noted in chapter 1 and also in section 4.4.2, arginine has always been thought 
as an aggregation suppressor at normal as well as high temperatures. There are 
numerous reports in the literature on how arginine suppresses protein aggregation 
(Tsumoto et al. 2005; Das et al. 2007; Liu et al. 2007; Ghosh et al. 2009; 
Schneider and Trout 2009). These reports suggest a few possible mechanisms, all 
centered around arginine’s effect on the solvent or the exclusion of arginine by 
the proteins (Kita et al. 1994; Tsumoto et al. 2005; Arakawa et al. 2007a; 
Schneider and Trout 2009). In addition to the use of a thermodynamic perspective 
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in explaining the effect of an additive, attempts have also been made to relate the 
functioning mechanism of the additive to specific molecular interactions of the 
additive with the protein molecule as we have discussed earlier in section 2.5.5. 
Ghosh et al. (2009) based on their circular dichroism and fluorescence 
measurements, suggest that arginine binds with the aromatic residues to suppress 
the population of aggregation-prone states of proteins. Supporting Ghosh et al.’s 
observations, Li et al. (2010) conclude based on their recent molecular dynamics 
simulations of solubilization of aromatic particles in the presence of arginine that 
the guanidinium group of arginine preferentially interacts with the aromatic and 
hydrophobic moieties on the proteins and thus prevent protein aggregation. 
 Although a detailed understanding of the above-described molecular 
interactions that are behind the action of additives on protein 
stabilization/enhancement are of considerable help in designing specific 
aggregation-inhibitory ligands, it is often difficult to gather such information 
using experiments alone. In such cases where experiments are insufficient, 
computational investigations serve as useful adjuncts. Therefore, to gain insights 
into how arginine interacts with different protein residues and to shed light on our 
experimental results, we have carried out density functional computations to 
identify key residues with which arginine interacts favorably. As noted in the 
previous section, our protein aggregation experiments show that guanidine 
enhances aggregation (if an enhancement occurs) more strongly than arginine 
(Figure 4.7), indicating that the enhancement observed in the presence of arginine 
is quite possibly linked to its guanidinium group. In addition, it has been indicated 
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that arginine’s interactions with amino acids is mediated through its guanidinium 
group (Arakawa et al. 2007a). Therefore, in our DFT calculations, to reduce 
computation time, we truncate the arginine molecule to its methyl guanidine part. 
Further, we focus on the interactions of the guanidinium group with the side 
chains of different residues, as guanidine is known to not interact with the protein 
backbone (Lim et al. 2009). The binding energies Eb between arginine and the 
amino acids were calculated for different possible orientations of each amino acid 
with arginine in order to identify the orientation corresponding to the maximum 
interaction energy. Because of the positive charge on arginine at neutral pH, the 
protonated form of arginine was used in the calculations; however, the neutral 
form was also considered wherever appropriate. Although we have calculated 
Eb’s for all the amino acids, for brevity, we focus here only on acidic amino acids 
as they have strongest interactions and on aromatic amino acids as they have been 
discussed repeatedly in literature. See Appendix A for more details on arginine’s 
interactions with other protein residues. 
 4.5.1 ARGININE’S INTERACTIONS WITH ACIDIC AMINO ACIDS 
 Arginine-acidic amino acids interactions involve the guanidinium group of the 
arginine and the carboxylate group of acidic amino acids, forming a guanidinium-
carboxylate salt bridge. A detailed theoretical study of the interaction of arginine 
with acidic amino acids has been presented previously by Melo et al. (1999), who 
showed that the zwitterionic form of the amino acids is more stable in an aqueous 
environment while the neutral form is more stable in vacuo. We observe a similar 
situation in our calculations as well. We also observe strong interactions of 
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arginine with acidic amino acids in the aqueous environment. Our calculations 
indicate that preferred conformations of the arginine/amino acid pair are those 
where it is possible to establish two hydrogen bonds of the type (N–H…O=C), 
where the two oxygen atoms of the carboxylate group of acidic amino acids share 
a partial negative charge, and the two N–H groups of arginine carry partial 
positive charge (Figure 4.9 A). There are two such interactions possible involving 
different nitrogen atoms of arginine. The results show a pronounced difference 
between the two conformations, with the hydrogen bonds of carboxylate with η1N 
and η2N being preferred over the hydrogen bonds with εN and η2N of the 




Figure 4.9: DFT calculations provide optimal geometries and binding energies 




 4.5.2 ROLE OF ARGININE-ACIDIC AMINO ACID INTERACTION IN 
AGGREGATION ENHANCEMENT  
 The DFT analysis reveals that arginine has strongest interaction with the 
acidic amino acids. Coincidently, we observe an enhancement in protein 
aggregation only for BSA and BLG, which have high acidic content, and do not 
observe enhancement for LYZ, which has low content of acidic residues. The 
amino acid contents of the three proteins, derived from sequence show that BSA 
and BLG have 16.3% (59 Glu & 40 Asp) and 14.6 % (16 Glu & 10 Asp) acidic 
amino acid content, respectively, in comparison with only 6.4 % (2 Glu & 7 Asp) 
in LYZ (Figure 4.10). This indicates that the enhancement of protein aggregation 
in the presence of arginine or guanidine is possibly related to their interactions 
with the acidic residues on the proteins. 
 
Figure 4.10:  Percentage amino acid content in BSA, BLG, and LYZ. The total 
number of residues in each case is indicated in parentheses.  
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 Based on our observations, we suggest herein that guanidine or the 
guanidinium part of arginine, using its bidentate capacity to simultaneously 
interact with two acidic residues, can act as a bridge to link the two proteins (see 
Figure 4.9D) and thus enhance protein aggregation. This speculation is supported 
by the high binding energies that we observe for such complexes from our DFT 
computations. The dependence of Cmin and Cthr on the protein concentration, 
observed in our experiments, also supports the above hypothesis, since at large 
arginine concentrations the acidic residues would become increasingly saturated, 
thus diminishing the enhancement of aggregation. In addition, to test the 
formation of proposed arginine-bridges, we have performed (similar to the 
molecular dynamics simulations by Li et al. (2010) on C20 fullerenes in arginine 
solution) simulations of C20 fullerene grafted with 2 acidic groups in 1 M arginine 
and guanidine (see Appendix B for detailed results). The results indicate that in 
the absence of any arginine or guanidine the particles are very soluble because of 
the surface charges (arising from the acidic groups). But in the presence of the 
additives these particles readily aggregate, with the additives acting as “bridges”. 
Moreover, the aggregation of grafted fullerenes is stronger in the presence of 
guanidine than arginine, which is consistent with the experimental observation on 
the enhancement of protein aggregation. We note, however, that the evidence 
available for the speculated bridge formation is circumstantial and that one cannot 





 4.5.3 ARGININE’S INTERACTIONS WITH AROMATIC AMINO ACIDS 
 Arginine’s effect on protein aggregation is discussed in the literature largely 
in terms of interactions of arginine with aromatic residues, as these interactions 
are more easily accessible through experimentation (Arakawa et al. 2007a; Ghosh 
et al. 2009; Li et al. 2010). Consistent with the literature, we also observe 
significant interactions of arginine with aromatic amino acids (tryptophan, 
tyrosine, and phenylalanine; only data for tryptophan are presented in Figure 4.9 
B and C as an example). It is generally observed that arginine forms parallel 
stacking interactions with the aromatic amino acids (Flocco and Mowbray 1994). 
These types of aromatic-arginine interactions, which are often found in locations 
critical to the activities of proteins, apparently serve to orient the arginine side 
chain without interfering with its ability to form hydrogen bond elsewhere. Long-
range interactions between arginine and aromatic residues have been reported by 
Martis et al. (2008); here, the cation from arginine interacts with the π cloud of 
the aromatic rings, forming a stacking cation–π interaction. In this type of 
interaction, the side chains of aromatic amino acids provide a surface of negative 
electrostatic potential that can bind to a wide range of cations through 
predominantly electrostatic interactions. Martis et al. (2008) performed detailed 
analyses on a number of different proteins to show that 31 % of the total Trp 
residues within the protein structure participate in such interactions with arginine. 
Martis et al. also observe that, amongst all the aromatic residues, the average 
energy of Arg-Trp interactions is the highest; however, Phe is shown to have the 
maximum number of such interactions. Recently, Ottiger et al. (2009) also studied 
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hydrogen bonding interactions between amino and aromatic moieties. They 
suggested that the formation of such a T-shape interaction is due to the hydrogen 
bonding of N–H…π nature. These interactions are amongst the weak 
intermolecular interactions found in proteins and play an important role in 
biological systems.  
 Although it is suggested in the literature (Flocco and Mowbray 1994) that 
parallel stacking interactions between arginine and aromatic residues are 
commonly found in protein structures and have high binding energies, we observe 
in our DFT calculations that the ‘T-shape’ interactions are slightly more favored 
than the parallel stacking interactions (by approximately 1.0 kcal/mol). This 
indicates that there is a competition between the parallel π-stacking and N–H…π 
hydrogen bond (T-shape) interactions. More interestingly, we observe that even in 
parallel stacking interactions the N–H group from arginine bends toward the 
aromatic ring (see Figure 4.9C, Arg-Trp stack) suggesting the presence of N–
H…π kind of interactions. We observe the highest Eb of arginine with Trp in 
aromatic amino acids, because the indole group of Trp provides a larger negative 
electrostatic potential than benzene or phenol, thus making Trp constitute a more 
attractive cation-binding site. 
   4.5.4 ROLE OF ARGININE–AROMATIC AMINO ACID IN STABILIZATION 
 Next, we focus on the role of arginine in stabilizing proteins against 
aggregation. Figure 4.7 contrasts the effects of guanidine on BSA and LYZ on the 
aggregation rate over a range of guanidine concentrations against the 
corresponding results for arginine. Clearly, guanidine shows no aggregation-
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inhibitory effect over a wide range of concentration (1 M), whereas arginine 
reduces aggregation for both proteins (after any initial enhancement, as discussed 
already). Additional control experiments with BLG using both guanidine and 
arginine lead to similar results (Figure 4.6). The fact that arginine causes a less 
drastic effect on aggregation at the same concentration as that of guanidine points 
to the role of the methylene groups and the polar end (including carboxylic and 
amine terminal) in mitigating aggregation. The role of methylene groups and 
polar end of arginine in stabilizing proteins against aggregation has also been 
highlighted by Li et al. (2010). The authors suggest that the guanidinium group, 
with its partial hydrophobic nature (Mason et al. 2004), binds itself to the 
aromatic or hydrophobic moieties on proteins; our DFT results also show high 
binding energies for such an interaction. Li et al. further show that the other end 
of arginine, i.e., the polar group, assists in the solubilization of the particles. The 
above results thus suggest that the guanidinium group of arginine has a dual role 
in modulating protein aggregation, i.e., although the guanidinium group 
contributes to enhancement of aggregation at low enough arginine concentrations, 
the group contributes to the stabilization of the protein by binding to 
hydrophobic/aromatic moieties on the protein and solubilizing the protein. In fact, 
the role of guanidinium group becomes more evident when we compare the effect 
of arginine with other structurally similar additives. Amino acids like leucine, 
isoleucine, or valine have aliphatic chain and the polar end similar to arginine, but 
are not aggregation stabilizers because they lack the guanidinium group. 
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4.6  CONCLUSION 
In summary, we show that arginine, contrary to the conventional thinking that it is 
a universal protein stabilizer, can induce and enhance aggregation depending on 
the choice and the concentration of the protein. The guanidinium group’s 
interactions with acidic amino acid residues on the proteins are shown to be 
behind the ability of arginine to be a destabilizer. Further the molecular 
architecture of arginine, i.e., the hydrophobic guanidinium end, aliphatic chain, 
and the hydrophilic polar terminal is correlated with aggregation suppression role 
of arginine. Our results add important molecular level perspectives, through 
amino-acid-level energetic changes resulting from the interactions of the additive 
with the protein residues and the consequent specific interactions and 
associations, to assist in the selection or design of effective additives. In the next 
chapter we specifically focus on arginine-aromatic interactions and draw attention 





5. ARGININE-AROMATIC INTERACTIONS 
AND THEIR EFFECTS ON ARGININE-
INDUCED PROTEIN STABILIZATION 
5.1  INTRODUCTION 
Protein aggregation, as well known, is driven largely by hydrophobic association, 
but interactions between aromatic groups are also known to play an important role 
in aggregation in several cases, as has been demonstrated for Islet Amyloid 
Polypeptide (IAPP) aggregation and phenylalanine zipper-mediated adapter 
protein with a PH and SH2 domain (APS) dimerization (Azriel and Gazit 2001; 
Reches and Gazit 2003; Dhe-Sirano et al. 2004; Liu et al. 2004b; Ma and 
Nussinov 2007b). In the previous chapter we concluded that arginine-aromatic 
interactions are sufficiently strong and can potentially play a dominant role in 
stabilizing proteins. As discussed earlier in chapter 2, the potential role of 
arginine-aromatic interaction has also been suggested in the literature. For 
example, Ghosh et al. (2009) suggest, based on circular dichroism and 
fluorescence measurements on BSA, that arginine probably binds to the aromatic 
residues to reduce the population of aggregation-prone states of proteins. More 
recently, Ariki et al. (2011) show, using solubility measurements of different alkyl 
gallates, that arginine has a strong effect on the solubility of aromatic compounds 
and suggest that the interactions between arginine and aromatic residues can assist 
to solubilize proteins. Despite such speculations on the role of arginine-aromatic 
interactions on arginine-mediated protein stabilization, there is very little 
information on the binding of arginine on aromatic residues and on the potential 
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molecular-level interactions that contribute to increased solubility of aromatic 
moieties and the stability of proteins. 
5.2 FOCUS OF THE CHAPTER 
In the chapter, we study the relative preference of arginine to bind to aromatic 
residues over other residues on proteins and discuss the possible implications of 
arginine/aromatic-residue binding on protein stabilization. Protein-protein 
interactions that cause aggregation and protein-additive interactions that counter 
aggregation are quite complex. Therefore, we begin with a small, aromatically 
rich model peptide, FFYTP, the B22-28 fragment of insulin, to examine the effect 
of arginine on the solubility of the peptide in water, as a measure of arginine-
induced peptide stabilization, and use mass-spectroscopy to study the binding of 
arginine with the peptide. To examine the nature of arginine-peptide binding and 
to identify the chemical groups on arginine and the peptide that participate in the 
binding we calculate the preferential interaction coefficients and the distribution 
of the heavy atoms of arginine around the peptide using molecular dynamics 
simulations. In addition to the experiments and simulations on the model peptide, 
we also examine the interaction of arginine with two proteins computationally, in 
order to gain a broader perspective on the role of arginine-aromatic binding in 
protein stabilization. In particular, we also look for the prevalence of arginine-
aromatic interactions in two model proteins (lysozyme and insulin) having 
different surface amino acid compositions and comment on the significance of 
such interactions on arginine-mediated stability of the proteins. 
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5.3 MATERIALS AND METHODS 
 5.3.1 MATERIALS 
 All the chemicals are procured from Sigma-Aldrich. Arginine (product 
number 11009) and 1X PBS buffer are used for all experiments. Peptide FFYTP, 
HPLC grade (>97.9% purity), was purchased from 1st BASE, Singapore and was 
used without any further purification. The peptide was capped at both N- and C-
terminals, by acetyl and amine groups, respectively.  
 5.3.2 FFYTP SOLUBILITY 
 The solubility of FFYTP peptide is measured by dissolving an excess amount 
of the peptide in PBS buffer containing 0 to 1 M arginine (pH adjusted to 7.4). 
Since the peptide is strongly hydrophobic and sparingly soluble, all the samples 
were mixed for 72 hours to achieve equilibrium. We observed that the time was 
sufficient for the solution to attain uniform turbidity. After mixing, the samples 
were centrifuged at 14,000 g for 60 min to remove all the insoluble particulates 
(Tsumoto et al. 2004; Hirano et al. 2008; Ariki et al. 2011). The supernatants 
were diluted 5-fold and the concentration of arginine was brought to 200 mM for 
all the samples before measuring the peptide concentration using UV absorbance 
at 280 nm. Since arginine has its own absorption peak at 280 nm, which is non-
linear with the additive concentration, the standard curve was prepared at 200 mM 
arginine and all the samples were adjusted to 200 mM arginine before measuring 
the peptide concentration. All the measurements were performed three times and 
the error bars are reported along with the results. 
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 5.3.3 ELECTRON SPRAY IONIZATION-MASS SPECTROSCOPY (ESI-MS) 
 ESI-MS is used to examine the binding of arginine with the FFYTP peptide. 
The mass spectra were acquired using Bruker Daltonics microTOF-II coupled 
with direct injections for electron spray ionization. Saturated solutions of the 
peptide at various arginine concentrations, as prepared above, were filtered (0.22 
µm) and used directly as samples for ESI-MS. Peptide solutions were 
continuously infused at a rate of 200 µl/hr into the ESI source along with nitrogen 
at 7 l/min and 0.4 bar as nebulizing gas. The mass spectra were obtained in 
positive mode with capillary voltage of 4.5 kV, end-plate voltage of −500 V, and 
heater temperature of 180 oC. All the mass spectra are presented as raw data on 
m/z scale, without any smoothing or resolution enhancement. At higher arginine 
concentrations (>200 mM) the peptide signal was over-shadowed by m/z 
corresponding to arginine and lower m/z peptide-arginine clusters. Therefore, we 
report data only for m/z above 600. 
 5.3.4 FFYTP SIMULATIONS  
 Molecular dynamics simulations are performed to study the effect of arginine 
on FFYTP aggregation. As in the case of the experiments, we capped the peptide 
with CH3CO and NH2 at the N-terminal and C-terminal, respectively. Three 
peptides are solvated in pure water and in 1 M arginine, each in a cubic box of 
side 8.5 nm. The initial configuration was generated using Discovery Studio 
(Accelrys®), with at least 3 nm distance between two peptides. The number of 
arginine molecules is adjusted as needed to achieve the desired concentration. All 
the simulations are performed using the GROMACS package. The peptide and the 
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arginine molecules are represented by the Gromos 96 force field, and the SPC 
model is used for water molecules. All the simulations are carried out at neutral 
pH. In the case of 1M arginine, an appropriate number of counterions are added to 
neutralize the total charge. Particle Mesh Ewald summation (PME) method is 
used to calculate the long-range electrostatic interactions with a grid-spacing of 
1.2 Å with a fourth interpolation. A cutoff of 12.0 Å is used for the short-range 
Coulomb and the Lennard-Jones interactions. All simulations are performed in the 
NPT-ensemble with the pressure maintained at 1.0 atm and the temperature at 
300K using Berendsen coupling method, and periodic boundary conditions are 
used. The simulations are run for at least 140 ns. 
 In addition, in order to calculate the preferential interaction coefficient, we 
have performed a simulation using only one peptide in 1 M arginine. The 
preferential interaction coefficient is calculated using the following equation 
(Baynes and Trout 2003; Shukla et al. 2009): 














where < > denotes the ensemble average, and the subscript X, P, W, and B stands 
for the additive, peptide, water, and bulk, respectively. The quantities nXP, nXB, 
nWP, and nWB thus stand for the number of arginine in the “vicinity” of the peptide, 
the number of arginine in the bulk, the number of water in the vicinity of the 
peptide, and the number of water in the bulk, respectively. Clearly, the calculation 
of ΓXP requires a clear demarcation between the “vicinity” of the peptide and the 
bulk. To do so, we first calculate the preferential interaction coefficient as a 
 88 
 
function of distance r from the surface of the peptide assuming any given r as the 
cut-off distance that separates the bulk from the “neighborhood” of the peptide. 
For such a calculation, the distance r from the surface of the peptide is divided 
into a number of “bins” (of 0.05 nm in width in our calculations). The numbers of 
arginine and water molecules (with the location determined by the centers of 
mass) for each snapshot are determined and assigned to the corresponding bins. 
The total numbers of water and additive molecules in the vicinity of the peptide 
(i.e., for any separation of the molecules less than r) are then counted and used in 
Equation 5.1 to determine the “preferential interaction function” ΓXP(r). Finally, 
the distance rb beyond which ΓXP(r) reaches a plateau defines the actual boundary 
between the vicinity of the peptide and the bulk, and the corresponding ΓXP(r) 
indicates the true preferential interaction coefficient. All other analyses on the 
peptide simulations were carried out using VMD (Humphrey et al. 1996). 
 5.3.5 PROTEIN SIMULATIONS 
 Molecular dynamics simulations of insulin (PDBid: 1HIU) and lysozyme 
(PDBid: 1E8L) in a 1 M arginine solution are carried out using AMBER 9.0 
program package to identify the residues on the proteins to which arginine binds 
preferably. All simulations employ the ff03 force field parameters for proteins and 
TIP3P model for water. The force field parameters for arginine are generated 
using antechamber module of Amber and the charges are derived using the RESP 
charge-fitting procedure. All other parameters are the same as the ones used in the 
peptide simulations. To setup the simulation system, the arginine molecules are 
placed at random positions in the simulation box containing a lysozyme/insulin 
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molecule and subsequently the box is filled with water molecules. Simulations are 
performed using a rectangular box (7.1×6.3×5.9 nm3). The system was 
equilibrated for 10 ns with a subsequent 25 ns production run for lysozyme; for 
insulin the equilibration run is for 30 ns and the production run is for 35 ns. 
5.4 RESULTS AND DISCUSSION 
In what follows, we begin with the experimental and MD simulation results on the 
FFYTP peptide to study the effects of arginine on the solubility/stability of the 
peptide and to identify the binding of arginine to the peptide. We also consider 
simulation results on two other model proteins (insulin and lysozyme) to examine 
the relative affinities of arginine to surface residues. Following these, a 
description of the molecular forces that are known to be behind the types of 
interactions seen between arginine and the peptide or the proteins and how these 
interactions could lead to inhibition of aggregation in the case of aromatic 
moieties and to reduction of aggregation-prone states in the case of proteins. 
Lastly, we offer our perspective on how reliance on preferential interaction 
coefficients alone can mask or obscure the significant role of the specific 
arginine/protein molecular interactions in stabilization. 
 5.4.1 ARGININE BINDS TO THE PEPTIDE TO ENHANCE THE SOLUBILITY (OR 
STABILITY) OF THE PEPTIDE 
 Arginine is known to enhance the solubility of various peptides, proteins, and 
other aromatic molecules (Arakawa and Tsumoto 2003; Baynes et al. 2005; Das 
et al. 2007; Ghosh et al. 2009; Hamada et al. 2009; Tantipolphan et al. 2010). 
However, as there are no reports available on the effects of arginine on the 
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stabilization of the FFYTP peptide, we first examine the effects of arginine on the 
solubility (or, stability in solution) of the peptide. To this end, we study the 
saturation solubility of the peptide in the presence of arginine. The results, shown 
in Figure 5.1, demonstrate that the solubility of the peptide increases linearly with 
arginine concentration. In the absence of arginine, the peptide is only sparingly 
soluble in the buffer and has a saturation solubility of 311 µM. In the presence of 
1 M arginine the solubility increases by 80% to 560 µM, indicating stabilization 
of the peptide against aggregation.  
 
Figure 5.1:  Arginine enhances solubility of the peptide Ac-FFYTP-NH2. Inset 
shows the peptide with aromatic residues (F1, F2, Y) colored with 
grey, peptide backbone with blue, and other groups (T, P) with 
green. 
  
 Mass spectroscopy experiments on saturated peptide solutions provide clues to 
the types of arginine/peptide interactions that contribute to the increased stability. 
Figure 5.2 compares the mass spectra of saturated peptide solutions for a typical 
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case with and without arginine. The results show that in the absence of arginine 
(Figure 5.2A) the peptide exists in monomeric form (a peak at m/z = 737.34 
corresponding to [peptide—Na]+ conjugate). However, in the presence of arginine 
(200 mM), one also sees, in addition to the original peak at m/z = 737.34, a peak 
at m/z = 889.47, corresponding to [pep—Arg]+ conjugate, with a relative intensity 
of 20% (Figure 5.2B), indicating binding of arginine with the peptide. All the 
other non-peptide peaks at low (<600) m/z in Figure 5.2B correspond to clusters 
of arginine. In addition to single arginine molecules, clusters of arginine also may 
contribute to arginine’s role as an aggregation suppressor, as we have discussed in 
our other work (see  Appendix C for further details) (Li et al. 2010).  
 
Figure 5.2: Mass spectra of saturated FFYTP in (A) PBS, showing [peptide—
Na]+ conjugate, and (B) 200 mM arginine, showing [peptide—Na]+, 
[peptide—Arg]+, and other arginine clusters in solution. Arginine, 
represented by symbol R, conjugates with the peptide in 1:1 ratio. 
 
With further increases in arginine concentration, the intensity of [pep—Arg]+ 
relative to [pep—Na]+ increases linearly and reaches a value of about 110% at 1 
M arginine, as shown in Figure 5.3 (see Appendix D for detailed mass spectra). 
Although it is frequently reported in the literature (Courtenay et al. 2000; 
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Parsegian et al. 2000; Timasheff 2002; Timasheff and Xie 2003) that preferential 
exclusion in general leads to stabilization, our mass spectroscopy experiments 
reveal that arginine, although it stabilizes the peptide solution, is not excluded 
from the peptide and that it in fact interacts favorably with the peptide forming 
1:1 conjugates. The binding of arginine to the peptide, as observed in our 
experiments, is crucial to arginine-induced peptide stability, as we shall discuss 
later.  
 
Figure 5.3: The MS intensity of [Pep-Arg]+ relative to [Pep-Na]+ at different 
arginine concentrations. The results indicate that the amount of 
[Pep-Arg]+ complex increases linearly with arginine concentration. 
For detailed mass spectra, refer to supplementary material. 
 
 5.4.2 MD SIMULATIONS REVEAL THE PREFERENCE OF ARGININE TO THE 
AROMATIC RESIDUES ON THE PEPTIDE 
 In order to gain detailed insights into the binding of arginine to the peptide we 
have performed molecular dynamics simulations of the peptide in 1 M arginine 
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solution. First, we examine whether a stabilization effect is seen as observed in 
the experiments. Protein aggregation and arginine-induced stabilization of 
proteins against aggregation are complex processes that are computationally 
demanding. As a result, there are currently no simulation studies that examine the 
anti-aggregation role of arginine on proteins/peptides from a detailed molecular 
perspective. The simulations here are done using three peptide molecules in a 
cubic box of side 8.5 nm, and the number of heavy-atom “atomic pairs” between 
the peptides is used to follow the dynamics of aggregation. An “atomic pair” is 
defined as a pair of two heavy atoms of different peptides within 0.5 nm. The 
results (Figure 5.4) show that in the absence of arginine the number of atomic 
pairs increases from 0 (no aggregates) to a value of about 160 within 3 ns, 
indicating the formation of an initial aggregate (dimer, in this case). Further, 
within 20 ns, the number of atomic pairs increases to about 450 and remains 
stable thereafter, marking the formation of a trimer of the peptides. 
 
 In contrast, the presence of 1 M arginine suppresses aggregation significantly, 
and the peptides remain essentially in the monomeric state up to 120 ns. (The 
peak one observes at 68 ns indicates the fleeting occurrence of peptide contacts.) 
One does see an increase in the number of atomic pairs beyond 120 ns even in the 
presence of arginine, but this is a consequence of the substantially high 
concentration of peptides used (about 8 mM) in the simulations to improve 
statistical accuracy. The saturation concentration of the peptide is roughly 0.6 mM 
in the presence of 1 M arginine, and one would see a complete suppression of 
aggregation when a correspondingly appropriate amount of the peptide is used in 
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the simulations. It also worth noting in this context that the π−π interactions 
between the aromatic residues which cause the peptide to aggregate are 
overestimated in the classical molecular dynamics force-fields (Tateno and 
Hagiwara 2009), and therefore the propensity of the peptides to aggregate in silico 
is highly enhanced. 
 
Figure 5.4:  Arginine at 1 M concentration strongly decreases the aggregation of 
FFYTP. The figure shows atomic pairs (defined based on heavy 
atoms of the peptide within 0.5 nm distance) between the peptides. 
These results are based on simulations performed on 3 peptides in a 
cubic box of 8.5 nm. In the presence of arginine, the peptides come 
close to each other for a short duration (64 - 74 ns), but do not 
aggregate. However, beyond 120 ns, even in the presence of 
arginine, the peptides form stable aggregate. 
 
 In addition to the number of heavy-atom atomic pairs used above, we have 
also measured the total Solvent Accessible Surface Area (SASA; including that 
accessible to arginine), which confirms the conclusions based on atom-pair 
calculations. In particular, in the absence of arginine SASA decreases from 30 to 
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20 nm2, indicating peptide aggregation. SASA, however, remains essentially 
constant at 30 nm2 in the presence of arginine (Figure 5.5). 
 
Figure 5.5: The presence of arginine (1 M) slows down aggregation of the 
peptide, as seen from the slower decrease in SASA. The total solvent 
(including arginine) accessible surface area shown is based on three 
peptides in the simulation box. 
 
 To identify the chemical groups on the peptide with which arginine associates 
closely, we have performed simulations of a single peptide molecule in a 1 M 
arginine solution in a cubic box of side 8 nm and calculate the preferential 
interaction coefficient for arginine and the “contact number” of the heavy atoms 
(defined below). Figure 5.6 shows the concentration distribution of (the center of 
mass of) arginine from the peptide surface, normalized with the bulk value. 
Consistent with the mass spectrum experiments discussed earlier, Figure 5.6 also 
shows binding of arginine with the peptide, with the maximum concentration of 
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arginine at about 0.2 nm from the peptide surface with a corresponding peak 
height of 2.7.  
 
Figure 5.6:  Arginine distribution around the peptide and preferential interaction 
coefficient show interaction (binding) of arginine with the peptide. 
Results are based on the simulations of a peptide in 1 M arginine 
solution. ΓXP (r) is calculated by defining region within r distance 
from the peptide surface as vicinity of the peptide and rest as bulk. 
Actual ΓXP reported is the asymptotic value (i.e., ΓXP = 1.6). The 
inset shows a typical snapshot from the simulation with the peptide 
(purple), arginine (cyan), and water (red). 
 
  As noted in chapter 2, ΓXP is used in the literature frequently to predict and 
describe the stabilizing effect of an additive. The above center-of-mass 
distribution can be used to determine the preferential interaction coefficient ΓXP of 
arginine with respect to the peptide. As described in the section on “Materials and 
methods”, one can calculate the “preferential interaction function” ΓXP(r) of an 
additive with respect to a protein using Eqn. (1) for any arbitrary delineation 
distance r separating the vicinity of the protein from the rest of the solution. The 
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function ΓXP (r) reaches a plateau at a distance rb, with the magnitude of ΓXP(r) at 
rb (and beyond) corresponding to the preferential interaction coefficient ΓXP. 
Figure 5.6 shows that rb is about 1 nm in the present case and that ΓXP is 1.6, 
indicating preferential binding of arginine to the peptide.  
 We next calculate the “contact number” of arginine around each residue on 
the peptide. The contact number is defined as the number of heavy atoms of 
arginine within a particular distance from the atoms of a residue of the peptide. 
The use of the contact number as a measure of the affinity, or lack thereof, of an 
additive incorporates the effects of all different types of inter-atomic and 
molecular interactions (e.g., hydrogen bonding, hydrophobic, van der Waals 
interaction, etc.) between the additive and the residues. The number of contacts 
shows the association of arginine with the residues and is approximately 
proportional to arginine-residue binding energy (Stumpe and Grubmuller 2007).  
 Figure 5.7, which shows the number of heavy atoms of arginine within 0.4 nm 
of each residue of the FFYTP peptide, indicates that arginine prefers aromatic 
residues over the other residues (threonine or proline) or the end terminals. 
Specifically, each of the aromatic residues has approximately 9 heavy atoms of 
arginine within 0.4 nm distance, whereas the others have only 3 to 6 heavy atoms. 
Since counting arginine atoms within 0.4 nm of a residue might also include some 
of the atoms of an arginine molecule that is bound to the neighboring residues, we 
have also used shorter cut-offs of 0.35 and 0.3 nm (see Figure 5.7), and the results 





Figure 5.7: Contact analysis (number of arginine heavy atoms within a particular 
distance of a residue) shows that arginine interacts mainly with the 
aromatics residues (i.e., F1, F2, and Y). Three choices for ‘contact 
distance’ (e.g., 0.4, 0.35, and 0.3 nm) are shown. 
 
An additional analysis of the distributions of CZ (carbon atom of the guanidinium 
group), CG (central carbon atom of the aliphatic side-chain), N (nitrogen atom of 
the amine terminal), and CC (carbon atom of the carboxylate terminal) atoms of 
arginine within 0.35 nm of each residue of the FFYTP peptide reveals that 
arginine interacts with the aromatic residues predominantly through the 
guanidinium group, with an average contact number of CZ for the aromatic 
residues being 0.43. The aliphatic segment of arginine (CG) also has a comparable 
contact number of 0.38, whereas the terminal ends of arginine have the lowest 





Table 5.1: Arginine associates with the aromatic residues predominantly 
through the guanidinium group. The table shows average number of 
central atom of guanidinium group (CZ), Aliphatic group (CG), 
Amine terminal (N), and Carboxylate terminal (CC) of arginine 




CZ CG N CC 
Ac 0.1 0.07 0.04 0.05 
F 0.41 0.33 0.16 0.11 
F 0.50 0.42 0.11 0.13 
Y 0.39 0.39 0.17 0.20 
T 0.25 0.16 0.08 0.11 
P 0.15 0.07 0.04 0.02 
NH2 0.13 0.09 0.03 0.05 
 
 
 5.4.3 ARGININE INTERACTS PREFERENTIALLY WITH THE ACIDIC AND 
THE AROMATIC RESIDUES ON THE PROTEINS 
 The results presented so far are based on an aromatically rich model peptide. 
However, since our choice of the peptide is based on its predominant aromatic 
content, it is important to examine how significant arginine-aromatic interactions 
are on full proteins, namely, in the presence of other types of residues. To this 
end, we present MD simulations results on the interactions of arginine with the 
surface residues of two model proteins, namely, lysozyme (pI = 9.8) and insulin 
(pI = 5.3). Although the two proteins have different surface charges and surface 
residue compositions, arginine is known to suppress aggregation in both cases 
(Okanojo et al. 2005; Hamada and Shiraki 2007; Lyutova et al. 2007; Matsuoka 
et al. 2007; Hamada et al. 2009). As evident from the pI values of the proteins, 
lysozyme has more basic residues on the surface, whereas insulin has more acidic 
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residues. Table 5.2 shows the number of heavy atoms of arginine within 0.35 nm 
from the surface residues of the two proteins. A surface residue is defined as the 
residue with solvent accessible surface area greater than 40% of the total residue 
area.  
Table 5.2: Average number of heavy atoms of arginine within 0.35 nm of the 
surface residues of lysozyme and insulin. Results based on molecular 
dynamics simulations of the proteins in the presence of 1 M arginine 
indicate that arginine interacts preferentially with the aromatic 
residues over others. 
 
 
Residues Insulin Lysozyme 
Acidic (D,E) 7.5  5.8 
Aromatic (F,W,Y) 5.8  4.5 
Aliphatic (A,I,L,V) 0.8 3.1 
Basic (R,K) 3.6 2.3 
Apolar (C,G,H,M,P) 1.0 1.5 
Polar (N,Q,S,T) 3.6 3.0 
 
For analyzing the results, we have divided the amino acids into six different 
categories: aliphatic (ALA, VAL, LEU, ILE); apolar (GLY, MET, PRO, CYS, 
HIS); polar (THR, SER, ASN, GLN); acidic (ASP, GLU); basic (ARG, LYS); 
and aromatic (PHE, TRP, TYR), and Table 5.2 presents the group average of the 
number of heavy atoms of arginine (see Appendix E for detailed results). The 
results show that for both proteins arginine has the highest number of contacts 
with the acidic residues on the surface. Arginine/acidic-residue interactions are 
strong due to the formation of a double hydrogen bonded structure of the type 
N−H…O=C (Melo et al. 1999).  
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 Our previous experiments for heat-induced aggregation did show that at large 
enough arginine concentrations arginine reverted to its well-known role as a 
suppressor of aggregation, which, we suggested based on density functional 
theory and molecular dynamics simulations (Li et al. 2010), is possibly due to the 
increasing importance of arginine-aromatic interactions at large arginine 
concentrations (the possible cause for which is discussed further in section 5.4.4). 
Our present results do indicate that arginine shows a preference for aromatic 
residues as well, although less so relative to acidic residues, for both insulin and 
lysozyme, despite the difference in the surface residue compositions of the two 
proteins. Interestingly, we observe a similar contact number (approximately 6) for 
the heavy atoms of arginine within 0.35 nm of the aromatic residues on the 
FFYTP peptide as for the two proteins (5.8 for insulin and 4.5 for lysozyme). The 
same trend has also been reported recently (Shukla and Trout 2010) for arginine’s 
interactions with α-chymotrypsinogen A. The similar patterns of interactions of 
arginine with the surface residues for three different proteins suggest that the 
observation might be valid for other proteins also. Furthermore, we observe from 
the distribution of CZ, CG, N, and CC atoms of arginine around the aromatic 
residues that for both the proteins the aromatic residues interact with arginine 
mainly through its guanidinium group and that the terminal ends of arginine have 
the least association with the aromatic residues. In particular, the contact number 
for CZ is 0.84 for insulin and 0.97 for lysozyme, whereas N and CC have a contact 
number of 0.07 and 0.19 for insulin and 0.31 and 0.27 for lysozyme, respectively 
(see Table 5.3). 
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 It is also noteworthy that, although in the case of FFYTP peptide we observe 
that the interactions of the aromatic residues with the guanidinium group (contact 
number for CZ atom = 0.43) and with the aliphatic segment (contact number for 
the CG atom = 0.38) of arginine are comparable, it is not so for the proteins. The 
results for the proteins show that, for both lysozyme and insulin, the contact 
number for CG is approximately half the contact number of CZ, indicating that the 
aromatic residues in the proteins have a significantly stronger interaction with the 
guanidinium group than with the aliphatic segment of arginine. 
 Finally, an observation concerning arginine’s interactions with aliphatic 
residues deserves mention. As well known, protein aggregation is mainly driven 
by interactions between hydrophobic (aromatic and aliphatic) residues. Das et al. 
(Das et al. 2007) speculate that the aliphatic side chain of arginine binds to the 
hydrophobic aliphatic residues on the protein (Aβ1−42, in their experiments) and 
this binding leads to protein stabilization. However, our results above reveal that 
for both the proteins we have used, arginine associates more strongly with the 
aromatic groups and that the interactions between arginine and aliphatic residues 





Table 5.3: Arginine associates with the acidic and aromatic residues on insulin 
predominantly through the guanidinium group. The table shows 
average number of central atom of guanidinium group (CZ), Aliphatic 
group (CG), Amine terminal (N), and Carboxylate terminal (CC) of 
arginine within 0.35 nm of each residue of insulin and lysozyme. 
Percentage surface residues are shown in the brackets.   
 
INSULIN CZ  CG  N CC 
Acidic (8%) 0.95 0.26 0.94 0.03 
Aromatic (15%) 0.84 0.43 0.07 0.19 
Aliphatic (15%) 0.23 0.05 0.00 0.01 
Basic (8%) 0.58 0.24 0.07 0.11 
Apolar (19%) 0.00 0.01 0.01 0.00 
Polar (35%) 0.3 0.07 0.35 0.15 
 
LYSOZYME CZ CG N CC 
Acidic (10%) 0.91 0.38 0.07 0.27 
Aromatic (5%) 0.97 0.44 0.31 0.27 
Aliphatic (10%) 0.42 0.33 0.00 0.13 
Basic (29%) 0.48 0.27 0.08 0.10 
Apolar (12%) 0.21 0.17 0.19 0.04 
Polar (34%) 0.33 0.19 0.02 0.08 
 
 
 5.4.4 THE POSSIBLE ROLE OF ARGININE-AROMATIC INTERACTIONS IN 
SOLUBILIZING PROTEINS  
 The results presented in the previous sections strongly suggest that arginine 
associates preferably with the aromatic residues on proteins through its 
guanidinium group. During aggregation proteins partially unfold, exposing a 
larger number of aromatic residues to the solvent environment. Since aromatic 
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residues frequently participate in protein aggregation (Dhe-Paganon et al. 2004; 
Liu et al. 2004a; Ma and Nussinov 2007a; Sawaya et al. 2007; Wang et al. 2010), 
arginine/aromatic-residue association is then expected to play an important role in 
arginine-induced stabilization of proteins by possibly reducing aggregation-prone 
states. In this section we comment on the intermolecular forces relevant in 
arginine/aromatic-residue associations and describe how these interactions lead to 
the solubilization of aromatic moieties and proteins.  .  
 Arginine-aromatic interactions have been studied earlier in the context of 
protein structures and protein-protein interfaces. For example, Flocco and 
Mowbray (1994) and Martis et al. (2008) have shown, based on bioinformatic 
analysis of the native structure of different proteins, that  arginine residues are 
often found in the vicinity of aromatic residues in proteins. Martis et al. (2008) 
have further shown that, in most of these arginine-aromatic pairs, it is the 
guanidinium group of arginine residue that interacts with the aromatic ring, in an 
orientation where the guanidinium plane aligns itself either in parallel or in a T-
shape configuration relative to the aromatic plane. Furthermore, in a series of 
studies Dougherty and coworkers (Gallivan and Dougherty 1999a, b, 2000; Beene 
et al. 2002; Beene et al. 2004; Dougherty 2007) have emphasized the 
predominant occurrence of cation−π interactions, i.e., between the cation of the 
guanidinium group of arginine and the π clouds of aromatic residues in proteins. 
Apart from their frequent occurrence within protein structures, arginine-aromatic 
interactions are also observed at various protein-protein interfaces (Crowley and 
Golovin 2005). Further, it is also known that, in addition to cation−π type of 
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interactions, other forces also assist in the association of arginine with an aromatic 
group. For example, molecular dynamics simulations and small-angle neutron 
scattering experiments by Mason and coworkers (Dempsey et al. 2004; Mason et 
al. 2004; Mason et al. 2007) show that the guanidinium group is poorly hydrated 
above and below its plane in aqueous solutions, thus exhibiting a hydrophobic 
behavior. This partial hydrophobicity induces the guanidinium group to interact 
with the hydrophobic plane of an aromatic residue, with the van der Waals forces 
contributing significantly to stabilize the pair (Li et al. 2010).  
 The above evidence available in the literature and the results of our 
simulations provide a picture of the molecular events that contribute to arginine’s 
affinity for aromatic residues. As we noted above, the guanidinium group of 
arginine can interact favorably with the aromatic plane in two different 
conformations, parallel and T-shape. However, hydrophobic and van der Waals 
interactions favor the parallel alignment over the T-shape configuration (Mason et 
al. 2007; Vondrasek et al. 2009), and thus cation−π, hydrophobic, and van der 
Waals interactions all contribute in tandem to bring arginine close to the aromatic 
residues. We also note that cation−π interactions are heavily underestimated in 
classical molecular dynamics calculations (Tateno and Hagiwara 2009). This 
would indicate that the high ‘contact number’ of arginine we observe with the 
aromatic residues (i.e., the frequency of arginine-aromatic association) in the case 
of the peptide as well as for the proteins in our simulations are still below what 
would be expected.  
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 Based on our earlier study (Li et al. 2010) on the solubilization of model 
aromatic particles in the presence of arginine, we have observed that arginine 
interacts closely with such particles and that the guanidinium group of arginine is 
closer to the aromatic-type groups than the polar and aliphatic segments of 
arginine. We have also suggested that the polar end of arginine, being 
hydrophilic, protrudes into the solvent and helps in solubilizing the particles. A 
similar phenomenon could be at play in the case of proteins, but in reducing 
aggregation-prone states. In particular, we observe that the guanidinium group 
(CZ) (and the aliphatic side chain (CG) of arginine, particularly, in the case of the 
FFYTP peptide) associates more frequently with the aromatic residues than the 
terminal ends (N and CC) suggesting that arginine masks the aromatic residues on 
the peptide/proteins through the guanidinium group (either in T-shape or parallel 
orientation), with the polar end of arginine faces the solvent helping to solubilize 
the proteins thereby contributing to the enhancement in their stability against 
aggregation.  
5.5 CONCLUDING REMARKS  
In summary, we have presented experimental and simulation results on the 
aromatically rich FFYTP peptide to show how arginine increases the solubility 
(and, hence, the stability) of the peptide and, by extension, aromatic moieties. The 
results show that the guanidinium group of arginine exhibits a preference for 
aromatic residues. Simulations on two proteins, lysozyme and insulin, also show 
arginine’s preference for aromatic residues over other residues with the exception 
of acidic residues. The guanidinium group of arginine again plays a major role, 
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even in the case of arginine’s interactions with acidic residues. Aromatic residues 
are known to drive protein aggregation (along with aliphatic residues). Our results 
suggest that arginine’s preferential interactions with aromatic residues could serve 
to increase the stability of proteins by reducing aggregation-prone states, as in the 
case of the FFYTP peptide, whose solubility is increased by arginine. 
 The results presented herein offer a caveat against relying solely on 
preferential interaction coefficients to predict the effect of arginine (or any 
additive) on protein stability. In our experiments with the FFYTP peptide, we 
observe stabilization of the peptide in the presence of arginine, although the 
preferential interaction coefficient is +1.6, indicating preferential binding of 
arginine to the peptide. These data and observations confirms that the preferential 
interaction coefficient alone is not always sufficient to infer or to explain the 
effect of an additive on protein aggregation. Finally, our results show that detailed 
molecular dynamics studies of an additive’s interactions with the individual 
residues of a protein would be highly useful in linking molecular level 
interactions and events to macroscopic thermodynamic interpretations of the 





6. CONCLUSIONS AND FUTURE WORK 
6.1  CONCLUSIONS 
This work focuses on identifying and examining the mechanism(s) through which 
arginine influences protein aggregation. In what is available in the literature 
currently, the effects of arginine, as well as those of other additives, on 
aggregation have been interpreted mostly in terms of the preferential interactions 
of the additives with the proteins (i.e., through the preferential interaction 
coefficients).  
 6.1.1 COARSE-GRAINED MOLECULAR THERMODYNAMIC MODEL OF 
AGGREGATION IN PRESENCE OF ADDITIVES 
 In the first part of this work, we have developed a molecular thermodynamic 
formalism based on liquid-state physics to study the effects of additives on 
aggregation equilibrium, in order to understand how and when preferential 
interactions lead to stabilization. Some of the key observations from the model 
are: 
 The excluded-volume effect (EVE), arising from hard-core 
interactions between the additive and the aggregating species 
(“reactants”) and between the additive and the aggregated 
structures (“products”), drives the aggregation reaction in the 
direction that maximizes the free volume in the system. Thus, 
in the context of protein aggregation, additives would 
enhance or suppress aggregation depending on whether the 
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protein molecule shrinks or swells during aggregation, 
respectively. 
 Preferential interactions, arising from the attractive or 
repulsive interactions between additive-reactant and additive-
product, drive aggregation to minimize the internal energy of 
the system. In the context protein aggregation, preferential 
binding (i.e., attractive interactions) will shift the equilibrium 
towards high additive-accessible surface area, whereas 
preferential exclusion (i.e., repulsive interactions) will do the 
opposite. The degree to which preferential interactions affect 
conversion is proportional to the strength of interactions. 
 Our results also show that a mixture of two additives can be 
more efficient in suppressing or enhancing aggregation than 
if either of the additives is used individually. 
 Further, the molecular thermodynamic model used also 
illustrates the effects of additive size, additive/protein 
interactions, and degree of aggregation on the equilibrium 
conversion. 
The above study brings to fore the fundamental principles one needs to 
understand the effects of additives on protein aggregation from a thermodynamic 
perspective. Although relying solely on thermodynamics can provide some 
understanding of the effects of additives, such an approach is often insufficient to 
reveal specific molecular interactions that cause protein stabilization. 
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 6.1.2 HEAT-INDUCED AGGREGATION 
 We next focused on identifying the molecular interactions of arginine with 
various protein residues and on understanding the role of these interactions in 
protein aggregation. Based on clues available in the literature we particularly 
looked at the role of the guanidinium group of arginine experimentally, using 
heat-induced aggregation of three model proteins in the presence of arginine and 
guanidine. The results reveal several important aspects about the way arginine 
functions. 
 We observe that arginine can also enhance (heat-induced) 
aggregation of concentrated protein solutions (~0.3 mM). 
However, the enhancement was not seen for all the proteins. 
In particular, we observe an enhancement in aggregation for 
BSA and β-lactoglobulin, but not for lysozyme. 
 However, arginine enhances aggregation only below a certain 
threshold arginine concentration (Cthr; ~150 mM). Moreover, 
at sufficiently high concentrations (i.e., beyond Cmin; ~ 800 
mM) arginine reverts to its known role as an aggregation 
suppressor. Both Cmin and Cthr depend on the choice of 
protein and increase with protein concentration. 
 Guanidine, on the other hand, also enhances the aggregation 
of BSA and β-lactoglobulin but has no effect on the 
aggregation of lysozyme. However, unlike arginine, high 
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concentrations of guanidine (~1.5 M) do not arrest 
aggregation.  
 The above observations, taken together,  suggest that the 
guanidinium group participates in the enhancement of 
aggregation and that the other segments of arginine, i.e., the 
aliphatic segment and the polar terminals, are necessary to 
suppress aggregation. 
 DFT calculations show that arginine can strongly bind to the 
acidic residues by forming a double-hydrogen-bonded 
structure. Our experimental results, DFT calculations, and 
simulations suggest that the enhancement in aggregation 
could be because of the formation of a bridge-like structure, 
where guanidine or the guanidinium group, using its 
bidentate capacity, simultaneously interacts with two acidic 
residues on two protein molecules. However, this hypothesis 
requires further tests. 
 DFT calculations also reveal strong interactions of arginine 
with aromatic residues in two different conformations 
(parallel stacks and T-shape). These interactions occur 
between the aromatic plane of the residues and the 
guanidinium group. We propose that these strong interactions 
between arginine and aromatic residues might play an 
important role in arginine-induced protein stabilization. 
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The above results suggest that the guanidinium group plays a dual role. At low 
concentrations, the guanidinium group binds to the acidic residues and can 
enhance protein aggregation, whereas at high concentrations it binds to the 
aromatic residues to suppress aggregation.  
 6.1.3 ARGININE’S INTERACTIONS WITH AROMATIC MOIETIES 
 Since aromatic residues participate frequently in aggregation, we also focused 
on identifying the role of arginine/aromatic-residue interactions in protein 
stabilization, using a short peptide, namely, the aromatically rich FFYTP segment 
of insulin, as our model. The study led to the following significant observations: 
 Arginine binds to the FFYTP peptide and enhances its 
solubility, and mass spectroscopy measurements reveal a 1:1 
stoichiometric binding of arginine with the peptide. 
Correspondingly, molecular dynamics simulations of the 
peptide in the presence of arginine show that arginine inhibits 
peptide aggregation, thus leading the way to higher 
solubility. 
 Measurements using mass spectroscopy show that arginine 
preferentially binds to the peptide, despite the fact that it 
suppresses the aggregation of the peptide. (Note that 
preferential binding is traditionally thought to promote 
aggregations.). Correspondingly, the preferential binding 
coefficient ΓXP  based simulations  is positive (and is equal to 
1.6). These results collectively show that relying solely on 
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preferential interaction coefficients to predict the effect of 
arginine (or any additive) on protein stability can be 
misleading. 
 We also observe from simulations that arginine preferably 
associates with the aromatic residues on the peptide. Such 
interactions are mediated by the guanidinium group of 
arginine, through cation−π, hydrophobic, and van der Waals 
interactions, all contributing in tandem to bring arginine close 
to the aromatic residues. 
 Simulations on two proteins, lysozyme and insulin, in 1 M 
arginine also show arginine’s preference for aromatic 
residues over other residues (with the exception of acidic 
residues). The results suggest that arginine’s preferential 
interactions with aromatic residues quite possibly play a 
strong role in increasing the stability of proteins. 
 Finally, the predominant and preferred orientation of arginine 
with respect to aromatic residues, namely, with the 
guanidinium group being closer to the aromatic residues than 
the polar and aliphatic segments of arginine, with the later 
protruding in to the solution, aids in the stabilization of the 
protein against aggregation.  In particular, the polar end of 
arginine, being hydrophilic, helps in “solubilizing” the 
aromatic residues and masks the protein from the aromatic 
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residues on other proteins, thereby decreasing aggregation-
prone states of a protein molecule. 
6.2 RECOMMENDATION FOR FUTURE WORK 
The present work sheds light on the mechanisms through which arginine 
influences protein aggregation, but there are a number of issues that require 
additional investigation. In this section we highlight some of the issues that need 
further investigation and offer some recommendations for future research. 
 6.2.1 FURTHER INSIGHTS INTO THE FUNCTIONING OF ARGININE 
 Our study shows that arginine can also enhance protein aggregation under 
certain circumstances. The DFT study along with the MD simulations (on model 
beads) presented in Chapter 4 indicates that arginine-bridges (i.e., simultaneous 
interactions of an arginine with two acidic residues) are energetically favorable 
and can contribute to an enhancement of aggregation when an arginine molecules 
interacts with acidic residues on two different protein molecules. However, 
additional studies to examine the presence of such bridges are needed for 
understanding the cause of enhancement of aggregation. Furthermore, our results 
also show that arginine prefers to interact with charged and aromatic residues on a 
protein (over other types of residues). We suggest that arginine/acidic-residues 
lead to enhancement in aggregation, whereas arginine/aromatic-residue 
interactions lead to suppression. However, the role of arginine’s interactions with 
other charged residues is not clear and needs further research. A practical way to 
explore the role of arginine’s interactions with charged residues in arginine-
induced enhancement or suppression of aggregation and also to examine the 
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arginine-bridge hypothesis is to perform atomistic-level simulations of 
aggregation of model peptides such as poly-glutamic acid or poly-arginine in the 
presence of arginine. These additional studies, in combination with our present 
work, can help in developing guidelines for the use of arginine (and can be 
extended to other additives as well) to stabilize a protein solution based on an 
analysis of the amino acid content of the protein. 
 A study with arginine homologues as additives can provide further insights 
into the functioning of arginine. For example, in a separate experiment (see 
Appendix F), we observed that both arginine and homoarginine have qualitatively 
and quantitatively similar effects on heat-induced aggregation of BSA and 
lysozyme. These results strongly indicate that the aliphatic segment of arginine 
does not play any significant role in the enhancement or suppression of protein 
aggregation. In addition, these results also shed light on the use of excluded-
volume effect and “gap effect” mechanisms used for explaining arginine-induced 
protein stabilization. Both these mechanisms suggest that the effect of an additive 
depends strongly on the additive’s size. Homoarginine is approximately 0.15 nm 
(i.e., C-C bond length) larger than arginine. If one assumes that the interactions of 
arginine and homoarginine with the protein are similar3
                                                 
3  Since arginine and homoarginine have essentially the same chemical groups, one can safely 
assume that both these additives have similar interactions with the protein. 
, then the gap effect would 
suggest that a 0.15 nm increase in the additive size would lead to a three-fold 
decrease in the aggregation rate of the protein. However, despite the size 
difference, homoarginine behaves the same way as arginine, indicating that gap-
effect (or the excluded-volume effect) has a negligible role, if any, on arginine-
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induced protein stabilization. Likewise, other comparative studies on the effects 
of different arginine homologues on protein aggregation will provide further 
insights into the functioning of arginine. 
 As noted earlier, the focus of the present work is on the role of the molecular 
interactions of arginine with protein residues and on the implications of such 
interactions on arginine’s influence on aggregation. In order to minimize any 
complications arising from the conformational changes of the protein occurring 
during the aggregation, we chose to use heat-induced aggregation (well above the 
melting temperature) so that all residues would be exposed to the solution, as 
described in chapter 4. While the use of heat-induced aggregation is helpful for 
clarifying some of the important issues, it needs to be complemented with 
aggregation experiments at normal temperatures. In general, partial unfolding 
precedes aggregation, and aggregation proceeds with the formation of 
intermolecular β-sheets. Thus, the conformations of the protein play an important 
role in aggregation. Monitoring the structural changes induced by arginine during 
aggregation can offer further insights into the functioning of arginine, in 
particular, about arginine’s preference to interact with a particular conformation 
of the protein. Although it has been reported earlier that arginine does not have 
any significant effect on unfolding of proteins, there is no study available, to the 
best of our knowledge, on the effects of arginine on secondary and tertiary 
structures of proteins. This is partly because of experimental constraints. Circular 
dichroism (CD) spectroscopy is generally used to characterize protein structure. 
However, because of arginine’s strong CD signal at 220 nm, CD spectroscopy 
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cannot be used to identify protein structures in the presence of arginine. A 
relatively easier way to suppress arginine’s CD signal is to use a racemic mixture 
of (L and D) arginine. In a separate experiment, we observed that at low arginine 
concentrations (~100 mM) a racemic mixture is able to significantly subdue 
arginine’s CD signal. However, beyond 100 mM even the racemic mixture has a 
random noise. Apart from CD, NMR and infrared spectroscopy are also used to 
study protein structures. However, both these techniques pose similar problems at 
high arginine concentrations. The possible choices to study protein structure in the 
presence of arginine thus are Raman spectroscopy and FTIR. 
 6.2.2 DESIGN AND USE OF SUITABLE ADDITIVES 
 Understanding the molecular interactions of arginine with protein residues 
naturally leads to rational selection and design of aggregation-inhibitory additives. 
For example, our study highlights that the guanidinium group of arginine binds to 
the aromatic residues and that this binding contributes to the stabilization proteins. 
We have also discussed that cation-π, van der Waals, and hydrophobic 
interactions, all contribute together in arginine/aromatic-residue binding. 
Modification, i.e., functionalization, of the chemical groups in arginine that 
enhance this binding (for example, addition of electron acceptor groups to the 
guanidinium terminal) will improve the efficiency of the modified arginine-based 
additive in suppressing aggregation. Moreover, enhancements in protein 
aggregation, which we suggest is due to arginine-bridge formation, can possibly 
be prevented by blocking one of the three amine terminals of the guanidinium 
group. There are several arginine-like molecules which can be used or modified to 
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design new additives. (Such arginine-like molecules include homoarginine (same 
as arginine but with an additional methylene group in the aliphatic segment), 2-
amino-3-guanidinopropionic acid (with one less methylene group), citrulline 
(guanidinium group replaced by urea), lysine (guanidinium group replaced by 
methyl-ammonia), various arginine-esters and -amides, arginine-aspartate and -
glumate, tosyl arginine (tosyl group attached to the guanidinium terminal), etc.) 
Moreover, because of high reactivity of the guanidinium group and of the polar 
terminal, chemical modification to arginine is relatively easy. 
 We also draw attention to another aspect of additive-induced stabilization, 
apart from the molecular mechanism(s) behind arginine’s influence on 
aggregation discussed thus far. It is known that equimolar mixtures of arginine 
and glutamic acid have stronger effects on suppressing aggregation of proteins 
(Golovanov et al. 2004) than the use of either arginine or glutamic acid. In a 
series of experiments not reported here, we also studied the effect of a mixture of 
additives on the aggregation of lysozyme and observed significantly stronger 
effects of the mixture relative to those of single additives. Golovanov et al. (2004) 
suggested that the basis for this remarkable effect lies in the capacity of the pair to 
neutralize opposite charges (which would otherwise lead to intermolecular 
association) on the proteins. These authors also proposed that the aliphatic 
segments of both additives mask the neighboring hydrophobic residues, thereby 
preventing aggregation. However, in chapter 4 and 5 of this thesis, we have 
shown that the aliphatic segment of arginine does not have any significant effect 
on the suppression protein aggregation. Thus, how a mixture of additives works 
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and why it is better are not fully clear. Therefore, we recommend a systematic 
study to identify the circumstances under which a mixture of additives works 
better. Such a study will be also useful for commercial applications. 
 Moreover, at present, the selection of a suitable additive and prevention of 
aggregation remain largely empirical due to a lack of insight into the molecular 
details of the aggregation process. To address this issue there have been some 
attempts to identify the aggregation-prone zones and/or aggregation-prone 
fragments of proteins. For example, Chennamsetty et al. (2009) have recently 
developed a technique to mark the hydrophobic moieties on proteins based on the 
hydropathy index of the individual residues. In addition, several studies on the 
peptide fragments from disease-related proteins have been conducted to identify 
the aggregation-prone zones of these proteins (Reches et al. 2002; Reches and 
Gazit 2003; Flöck et al. 2006; Zhang et al. 2009; Lin et al. 2010). It is also now 
possible to extract atomistic details of peptide aggregates using XRD, NMR, or 
molecular dynamics studies on the aggregation of the above-mentioned fragments 
(Lin et al. 2010). Similar studies to identify the aggregation-prone zones and/or 
aggregation-prone fragments of pharmaceutical proteins will be of great help. 
Mutagenesis and developing analogous proteins to reduce aggregation then seem 
to be a direct approach to tackle aggregation. However, mutagenesis approach is 
generally not preferred for pharmaceutical proteins because this would require 
extensive clinical trials to document the lack of other adverse effects. More 
recently, based on the knowledge of aggregation-prone fragments of fibrillating 
proteins, the use of self-recognizing-elements (SRE) has been introduced (see for 
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example, Amijee et al. (2009) and references therein). SREs are the fragmental 
peptides of the aggregating protein, used as additives. These can bind to the 
growing edges of the aggregates through hydrogen bonding but prevent further 
aggregation due to their small size or by the inclusion of ‘β-breaker’ (generally 
proline or N-methyl) residues. Because of their high-degree of specificity, these 
SREs are extremely effective even at nano-molar concentrations. For example, it 
is known that the KLVFFAE segment is the aggregation prone zone of beta-
amyloid peptide (Gazit 2005). Using this knowledge, Amijee et al. (2009) 
designed D-[(chGly)-(Tyr)-(chGly)-(chGly)-(mLeuc)]-NH2 (where ch is 
cyclohexyl and m is N-methyl) and D-{His-[(mLeu)-Val-Phe-Phe-Leu]-NH2} 
SRE peptides that can inhibit Aβ aggregation even in micromolar concentrations. 
Future research in the direction of identifying the aggregation-prone zone of 
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Table A1:   Binding energy (Eb at 0 K) and Gibbs free energy of binding (Gb at 
298.15 K) of each amino acid with arginine calculated at GGA-
PW91 level. All the energies are in kcal/mol.a   
 
Amino acid Eb 0K  Gb298.15K   
Asp –35.52  –20.84  
Glu –34.72  –21.03  
Asn –23.81  –12.51  
Gln –24.39  –13.69  
Trp –17.82  –4.17  
Tyr –17.50  –4.18  
Phe –17.34  –4.50  
Pro –18.01  –4.95  
Ser –19.83  –10.03  
Thr –18.61  –5.28  
Arg –30.57  –20.84  
Lys –12.54  –1.23  
His –23.11  –10.64  
Cys –23.42  –10.10  
Met –18.67  –5.14  
Ala –15.05  –6.13  
Val –13.49  –0.69  
Leu –14.31  –1.36  
Ile –12.92  –0.04  
 
 
a Both the binding energy and the Gibbs free energy reported herein are inclusive 







Figure B1:  Molecular dynamics simulations of C20 fullerene grafted with 2 
acidic (−COOH) groups at opposite ends in the presence of arginine. 
The figures show radial distribution functions and coordination 
number of the fullerene particles. See Li et al. for simulation details. 
Both radial distribution function and coordination number indicate 
that in the absence of arginine there is no aggregation of the 
particles. However, in the presence of arginine, we observe 
concentration-dependent aggregation of the particles, with maximum 
aggregation observed in the presence of 250 mM. The results are 
qualitatively similar to those observed in our heat- induced 
aggregation of acidic proteins. Visual observations show formation 






Figure B2:  Molecular dynamics simulations in the presence of guanidine. 
Although in the absence of guanidine there is no aggregation, 
similar to arginine, we observe enhancement in the aggregation of 
the particles in the presence of low concentrations of guanidine. At 
same concentration guanidine enhances aggregation of the particles 
more than arginine. The results are qualitatively similar to those 
observed in our experiments. At high enough guanidine 
concentrations, 6 M, which is generally used to solubilize protein 





CLUSTERING OF ARGININE IN BULK SOLUTION  
It has been claimed in the literature (Das et al.) that the clustering of arginine in 
the solution causes inhibition of hydrophobic associations because of the creation 
of a “hydrophobic environment” in the solution. It is also further speculated 
therein that the cluster formation occurs due to the alignment of the three 
methylene groups of arginine with those of the other arginine molecules. In 
another work (see Li et al.) in our lab we have performed MD simulations of 
arginine solution at low and normal pH. The MD simulations clearly indicate that 
arginine molecules do form clusters at normal pH but not at low pH, as suggested 
by experiments of Das et al. However, the results also indicate that arginine form 
“head-to-tail” clusters due to electrostatic interactions rather than through the 
alignment of the aliphatic chains. The head-to-tail association at normal pH is 
reasonable in view of the strong electrostatic interactions between the oppositely 
charged carboxyl groups (COO−) and guanidinium groups stabilized by double 
hydrogen bonds; indeed, such an association has been identified in many 
complexes involving biomolecules. Arginine at low pH (ARGp) does not form 
clusters because of the weak hydrogen bonding ability of COOH group compared 
to that of the COO− group, which supports the available experimental reports. The 
absence of arginine clusters at low pH suggests that the complexes involving 
multiple hydrogen bonds (e.g., structures formed by two hydrogen bonds; see 






Figure C1: One of the stable conformations of arginine in solution. The 
illustration shows the head-to-tail association mediated by the 
double hydrogen bonds between polar and guanidinium groups. 
  
 Further, the MD results on aggregation of hydrophobic particles in the 
presence of arginine also showed that the clustering of arginine in the bulk 
solution does not significantly influence the solubilization or suppression of 
aggregation. However, the self-association of arginine through the “head-to-tail” 
association mentioned earlier does appear to aid solubilization or suppression of 
hydrophobic association, not by creating a “hydrophobic environment” in the bulk 
solution, but by forming a ‘cage-like’ structure around the hydrophobic moieties. 







Figure D1:  Detailed mass spectra of FFYTP peptide at different arginine 
concentrations. Since the low m/z region (< 550) was crowded by 
non-peptide peaks, we report data only for m/z beyond 600. 
 
(a) 0 M arginine 
 
(b) 200 mM arginine 
 
(c) 400 mM arginine 
D2 
 
(d) 600 mM arginine 
 
e) 800 mM arginine 
 









Table E1: Heavy atoms of arginine within 0.35 nm of the surface residues of 
insulin and lysozyme. Data based on molecular dynamics simulations 
of the proteins in the presence of 1 M arginine.    
 
INSULIN LYSOZYME 
Residue Arginine atoms* ASA** Residue Arginine atoms* ASA** 
G 1 1.59 0.47 K 1 4.79 0.71 
T 8 1.26 0.66 V 2 6.10 0.47 
I 10 0.08 0.43 R 5 0.61 0.76 
Y 14 5.85 0.77 E 7 8.44 0.90 
Q 15 0.10 0.4 K 13 5.09 0.50 
N 18 5.94 0.67 R 14 3.23 0.92 
N 21 9.51 1.00 D 18 8.24 0.63 
F 22 0.94 0.96 N 19 3.67 0.81 
V 23 0.53 0.63 R 21 1.35 0.95 
N 24 1.09 0.68 Y 23 2.22 0.47 
Q 25 1.26 0.55 F 34 1.47 0.43 
H 26 1.14 0.4 N 37 1.55 0.83 
C 28 0.40 0.41 Q 41 4.39 0.57 
S 30 3.42 0.76 T 43 11.43 0.58 
H 31 1.39 0.5 N 44 14.09 0.50 
V 33 1.40 0.41 R 45 0.94 0.70 
E 34 7.56 0.43 N 46 7.26 0.40 
Y 37 6.25 0.52 T 47 4.82 1.00 
L 38 1.30 0.56 D 48 10.44 0.69 
E 42 7.52 1.00 R 61 0.89 0.43 
R 43 3.35 0.65 W 62 9.83 0.47 
G 44 0.28 0.4 N 65 1.88 0.63 
F 46 10.22 0.81 G 67 2.50 0.75 
T 48 2.51 0.68 R 68 0.87 1.00 
K 50 3.81 0.99 P 70 0.83 0.80 
T 51 7.53 1.00 G 71 2.54 0.84 
* Heavy atoms of arginine within 0.35 
nm of the residue. 
**fraction of the total residues area 
exposed to the solvent. 
R 73 7.97  0.69 
L 75 0.93  0.54 
N 77 0.29  0.82 
P 79 1.01  0.49 
S 81 0.30  0.82 
E2 
 
S 85 0.14  0.63 
S 86 0.06  0.64 
D 87 0.52  0.44 
T 89 0.52  0.44 
K 97 0.11  0.62 
S 100 2.96  0.55 
D 101 4.79  0.87 
G 102 2.49  0.79 
N 103 0.14  0.43 
N 106 0.18  0.48 
A 107 0.29  0.43 
V 109 1.12  0.66 
R 112 1.35  0.55 
N 113 0.23  0.80 
R 114 0.74  0.68 
K 116 0.42  0.66 
G 117 0.73  1.00 
T 118 0.40  0.60 
D 119 2.18  0.71 
Q 121 2.95  0.70 
A 122 0.00  0.49 
R 125 1.03  0.93 
G 126 0.47  0.93 
R 128 5.60  0.97 







Figure F1: The figure compares the effects of arginine and homo-arginine on the 
heat-induced aggregation of BSA. See section 4.3 for methodology. 
The results indicate that the aliphatic segment of arginine has 
negligible role in enhancing or suppressing aggregation. The results 
also indicate that the size of arginine molecule is not a significant 
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